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ABSTRACT 
 Understanding how cell fate decisions are regulated by signaling pathways and 
transcription factors is key to understanding how embryonic development takes place. 
Neural crest cells are an embryonic cell type that must undergo several cell fate choices 
and changes in gene expression before they are able to finally differentiate and contribute 
to adult tissues. Neural crest cells are formed at the border between developing neural 
and non-neural ectoderm in a region called the neural plate border. They are induced by 
several signaling factors and specified by the expression of transcription factors which 
will form a gene regulatory network for their development and control subsequent 
programs within the neural crest cells such as epithelial-to-mesenchymal transition, 
migration, and differentiation, which are required for proper development of the embryo. 
One transcription factor that is required for neural crest specification is the PR/SET 
domain containing transcription factor Prdm1a. The goal of this thesis is to explore the 
mechanisms by which Prdm1a regulates genes required for neural crest specification and 
migration. Prdm1a is expressed in the early neural plate border, and when its expression 
is abrogated, neural crest cells are significantly reduced. Here, I have demonstrated that 
Prdm1a is downstream of known signaling pathways that induce neural crest cells, 
specifically Wnt and Notch signaling. Prdm1a directly activates the expression of the 
neural crest specification genes foxd3 and tfap2a, which are also required for neural crest 
formation. In addition to its role as a transcriptional activator, Prdm1a is also required as 
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a transcriptional repressor of yet unknown targets and this role is required for specified 
neural crest cells to continue development to migratory stages. Using whole-genome and 
transcriptome approaches, I was able to identify several novel targets of Prdm1a 
regulation, demonstrating its role as a master regulator of several genetic programs 
required for the formation of the neural crest and possibly other tissues as well including 
the neural plate and sensory placodes. Interestingly, one of the downstream targets of the 
Prdm1a regulatory network is a cell adhesion gene, cdon. I have demonstrated a novel 
role for cdon as a cell-autonomous regulator of neural crest motility and migration. 
Altogether, this work demonstrates the importance of the Prdm1a transcription factor and 
how Prdm1a and its downstream gene regulatory network influences and controls neural 
crest cell fate. 
 
The format and content of this abstract are approved. I recommend its publication. 
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Embryonic development, the process of transforming a single cell, the fertilized 
egg, into a complex, multi-cellular organism, is made possible by a series of cell fate 
choices. Upon each division, a cell that is genetically identical to every other cell in the 
embryo must undergo a program of differential gene expression which will drive the cell 
to become its final fate. Understanding how these programs are initiated by external cues 
and how genes are then expressed or inhibited to lead to specification and differentiation 
of multiple cell types is a crucial and ongoing field of study.  
Neural crest cells (NCCs) are a population of embryonic progenitor cells present 
in all developing vertebrate embryos. They give rise to a variety of adult tissues including 
neurons and glia of the peripheral nervous system, cranial ganglia, cartilage and bones of 
the face, sympatho-adrenal cells, and pigment cells. Neural crest fate is specified from the 
developing neural ectoderm during a highly complex process of signaling, gene 
expression, and regulation. The neural crest program (Figure 1.1) is initiated along the 
border of the neural plate and non-neural ectoderm. Signals from the surrounding tissues 
including the underlying mesoderm and within the ectoderm coincide to specify the 
region known as the neural plate border (NPB). This region of tissue is specified by 
various transcription factors known as “NPB specifiers”, which are downstream of the 
initiation signals. After specification of the NPB, the NPB specifiers are then able to turn 
on the next wave of transcription factors which are required to specify the NCCs 
themselves. These “neural crest specifiers” mark the birth of the neural crest within the 
NPB. The neural tube which is formed from the neural plate begins to fold bringing the 
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two lateral NPB domains together at the dorsal midline of the neural tube. During this 
period, the ectodermal NCCs begin a process of changing from highly adhesive, tightly 
interacting epithelial cells to individual migratory cells. This process is known as an 
epithelial-to-mesenchymal transition (EMT). This process allows the NCCs to migrate 
out from the neural tube and ventrally through the embryo to reach their final 
destinations. Receiving cues from the migratory and post-migratory environment, NCCs 
are then able to fully differentiate into their final fate.  
Throughout development of the embryo, NCCs are making cell fate choices at 
each stage which are required for their proper formation and contribution to adult tissues. 
Many genes are required for NCCs to be specified and many studies have been devoted 
 
Figure 1.1. Stages of neural crest development and important genes. 
NCCs are induced by several signaling pathways which initiate specification of the 
NPB. These transcription factors go on to specify the neural crest by inducing 
expression of neural crest specifier genes. NCCs then undergo a process of EMT and 




to the characterization of the gene regulatory network required for neural crest 
development. However, the understanding of these genes and how they are regulated is 
not complete and new genes are frequently discovered to have novel roles in NCCs. One 
of these genes encodes the transcription factor Prdm1a, and the body of this work strives 
to understand how this one factor plays a large role in NCC specification and 
development. 
The neural crest: evolution and development 
 NCCs are a transient population of progenitor cells that are born from the dorsal 
neural tube during vertebrate embryonic development. They go through several stages of 
development which are tightly regulated by the initiation of various transcription factors 
and effector genes at each step. NCCs are highly conserved throughout vertebrate 
development, allowing developmental biologists a large array of embryonic model 
systems and tools to study their development and behavior. Zebrafish are an excellent 
experimental model for the study of neural crest development due to the accessibility of 
very early developmental stages for observation and the ease of use of experimental 
manipulations such as morpholino knockdowns and genetic mutants, pharmacological 
treatments, and transplantation experiments as well as tools such as RNA in situ 
hybridization, transgenics, and live-imaging that allow for rapid analysis and comparison 
of gene expression and cell behaviors. Utilizing these techniques, we have been able to 






Neural crest induction and specification 
While the major events and many of the genes required for neural crest 
development are conserved among vertebrates, the timing and specific genetic 
interactions of this process do display some species-specificity. In zebrafish and Xenopus, 
the NPB, which occurs at the junction of neural and non-neural ectoderm, is induced 
during the latter half of gastrulation with border markers being expressed as early as the 
beginning of gastrulation or mid-epiboly stage in zebrafish. Evidence suggests that the 
ectoderm is patterned by a gradient of BMP signals that involves both secretion of BMP 
from the ectoderm as well as BMP-antagonists from the dorsal mesoderm (Aybar and 
Mayor, 2002). A high level of BMP specifies the epidermis while inhibition of BMP to 
low levels is required to promote neural fates. The neural crest is induced at BMP levels 
intermediate to those necessary for these two other fates in the NPB. Several studies have 
also shown that other signaling molecules including FGF, retinoic acid, Notch, and Wnt 
are crucial in the regulation of neural crest induction, maintenance, and specification in 
all vertebrate model species (Huang and Saint-Jeannet, 2004). These pathways likely 
interact to create redundancies, allowing for neural crest induction to proceed in the 
absence or perturbation of one or more of these signals. The specification of cells in the 
NPB to commit to neural crest fate occurs at the end of gastrulation and beginning of 
segmentation around the 2-somite stage in zebrafish. During these stages, several neural 
crest markers encoding transcription factors that have been found to be necessary for 
specification, the neural crest specifier genes, begin to be expressed in the NPB. These 
include foxd3 (Lister et al., 2006; Montero-Balaguer et al., 2006; Stewart et al., 2006), 
snai1b or slug (Thisse et al., 1995), tfap2a (Barrallo-Gimeno et al., 2004), and sox10 
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(Dutton et al., 2001). These transcription factors are responsible for regulating genes 
required for the next steps in neural crest development including EMT and migration. 
How they are regulated and in turn regulate one another is a fascinating yet poorly 
understood process. It is clear that they cooperate to form the gene regulatory network for 
neural crest specification, but how the transition from NPB cells to NCCs occur and how 
these transcription factors interact with one another is still poorly understood. 
Epithelial-to-mesenchymal transition 
After specification, the premigratory NCCs receive cues from both the 
extracellular matrix (ECM) as well as secreted ligands such as TGFβ and FGF family 
members that cause the NCCs to undergo EMT (Sauka-Spengler and Bronner-Fraser, 
2008). During EMT, there are changes to the cytoskeletal elements and cell junctions of 
the NCCs that alter their motility and adhesion. There is a downregulation of 
characteristic epithelial genes such as the adhesion genes E-cadherin, claudins, and 
occludins and the upregulation of mesenchymal markers such as fibronectin, vitronectin, 
and vimentin. The Snail genes which are turned on during neural crest specification 
initiate EMT by repressing N-cadherin and thereby mediating the switch to a 
mesenchymal phenotype in chick embryos (Cheung et al., 2005). In chick and Xenopus, 
loss of Snail family members results in a failure of EMT, and failure of NCC 
delamination and migration (Nieto et al., 1994; LaBonne and Bronner-Fraser, 2000). 
Similarly, in zebrafish, loss of the Snail transcription factors results in massive embryonic 
failure of EMT in multiple tissues (Blanco et al., 2007). Further transcription factors 
including the Zeb family and basic helix-loop-helix (HLH) family members including 
Twist1, E proteins, and Id HLH proteins also have a demonstrated role in EMT through 
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downregulation of E-cadherin and other mechanisms. The downregulation of E-cadherin 
coincides with the upregulation of N-cadherin and Cadherin-6b which initially defines 
the neural ectoderm and premigratory NCCs in zebrafish, mouse, and chick (Nakagawa 
and Takeichi, 1995; Inoue et al., 1997; Liu et al., 2006). This cadherin switching appears 
to be critical for cells to acquire a motile phenotype (Wheelock et al., 2008). The 
downregulation of N-Cadherin and Cadherin-6b occurs prior to NCC migration while 
expression of a less adherent type 2 cadherin such as Cad7 in chick and Cad11 in mouse 
and Xenopus is upregulated
 
(Nakagawa and Takeichi, 1995; Nakagawa and Takeichi, 
1998; Vallin et al., 1998; Cheung et al., 2005). This allows the NCCs to detach from their 
neighbor cells and begin to migrate from the neural tube. However, the role of N-
cadherin and cadherin switching in zebrafish NCC migration remains unclear. 
Neural crest migration and differentiation 
Once delamination from the dorsal neural tube occurs, NCCs are able to migrate 
ventrally toward their final tissues. NCCs located most medially within the dorsal neural 
tube appear to migrate first with more lateral cells following (Krispin et al., 2010). In 
chick, zebrafish, and frog, NCC migration begins at neural tube closure whereas in the 
mouse, migration is initiated prior to full neural tube closure. Upon delamination, NCCs 
receive multiple environmental cues that guide their migratory pathway and ultimately 
help them reach their final destination and differentiate into their final fate. First, the cells 
must break down the ECM through which they migrate using matrix-metalloproteinases 
(MMPs) that degrade components of the ECM. MMP-2 and MMP-8 are expressed as 
NCCs exit the neural tube and begin migrating (Cai et al., 2000; Giambernardi et al., 
2001) and are required for NCC migration (Duong and Erickson, 2004; Anderson, 2010). 
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Another family of metalloproteinases, ADAMs, are also involved in NCC migration. In 
Xenopus, ADAM9 and ADAM13 are required for breakdown of the ECM by cranial 
NCCs (Alfandari et al., 2001) and the cleavage of cadherin-11 (McCusker et al., 2009). 
Once NCC migration begins, both attractive and inhibitory signals from the 
environment guide their movement. A positive cue for neural crest migration is the 
chemokine SDF1/CXCL12 from the microenvironment, which activates the CXCR4 
receptor within migrating NCCs. Expression of the SDF1 ligand in the pharyngeal arches, 
along with expression of the CXCR4 receptor in the anterior migratory stream of NCCs, 
is necessary for proper migration of the cranial neural crest to populate the craniofacial 
region in zebrafish (Olesnicky Killian et al., 2009) and Xenopus (Theveneau et al., 2010). 
Similarly, SDF-1/CXCR4 signaling is also required in the mouse trunk in order for NCCs 
to migrate and populate dorsal root ganglia (Belmadani et al., 2005). Directed migration 
of NCCs also relies on inhibitory signals to keep the migrating cells spatially organized. 
The key signals involved in this process are the ligands ephrin and semaphorin. They are 
expressed in regions where the NCCs do not normally migrate, such as the scleratome in 
the trunk or the tissues in between streams of migrating cells within the trunk and face 
(Krull et al., 1997; Theveneau and Mayor, 2012). The receptors for these ligands, Eph 
and neuropilin respectively, are expressed by the NCCs themselves. Activation of these 
signaling pathways prevents migration of NCCs into specific zones by inducing collapse 
of cellular projections (Theveneau and Mayor, 2012). Loss of normal Eph/ephrin or 
neuropilin/semaphorin signaling results in ectopic migration of neural crest into other 
tissues and mixing of neural crest streams, ultimately preventing proper patterning of the 
embryo (Smith et al., 1997; Gammill et al., 2006; Schwarz et al., 2009). 
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Another crucial aspect of NCC migration is proper polarity of migrating cells. As 
NCCs receive attractive chemokine signals such as SDF1, they polarize themselves with 
the leading migratory edge, characterized by expression of the actin cytoskeleton 
organizer Rac which leads to formation of stable protrusions and lamellopodia, facing 
toward the positive migratory cues. The trailing edge of the cell expresses high levels of 
Rho and does not form stable protrusions, thereby allowing the cell to move toward the 
signaling source. This cell polarization is aided by contact-inhibition of locomotion, 
where cells that migrate collective, such as cranial NCCs, collapse protrusions and move 
away from one another when they contact (Carmona-Fontaine et al., 2008). This allows 
clusters of migrating cells to be polarized in the front or leading edge of leading 
migratory cells while inhibiting the follower cells from creating protrusions to migrate 
away from the group. NCC polarity is also thought to be regulated by Wnt/PCP signaling 
which regulates expression of Rac/Rho (Matthews et al., 2008) and by Connexin43 which 
modulates gap junctions (Xu et al., 2006; Francis et al., 2011). When polarity is ablated 
by interfering with one or more of these regulatory pathways, directed migration of NCCs 
is lost, demonstrating the importance of cell polarity in neural crest migration. 
As NCCs reach their final destinations, they undergo differentiation into their 
final cell fate. This involves the downregulation of migratory genes, possibly through a 
mesenchymal-to-epithelial (MET) process. They turn on genes required for 
differentiation into their adult tissue type, such as mitfa for melanocytes, glial and 
neurogenic programs, or genes to induce cartilage formation. It is thought that this occurs 
through signaling with the final surrounding tissues such as occurs in the pharyngeal 
arches where cartilage will form, or from a combination of cues during and after 
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migration. The process by which this occurs is still unclear and appears to be specific to 
each cell type. 
Evolution of the neural crest 
True NCCs are a completely vertebrate feature of development; they are not 
found in invertebrate organisms. There is evidence, however, of the evolution of NCCs in 
the two clades of invertebrate chordates that are thought to be the closest living relatives 
to vertebrates: the urochordate tunicates or ascidians, which possess a cell type that has 
similar characteristics to the vertebrate neural crest and is therefore thought to be a more 
ancestral form of NCCs, and the cephalochordate amphioxus, in which the expression of 
various vertebrate neural crest genes has been analyzed. In one species of ascidian, 
Ecteinascidia turbinata, anterior neural tube cells were fate-mapped during development 
and found to migrate ventrolaterally and form pigment cells, one of the major derivatives 
of vertebrate neural crest (Jeffery et al., 2004). It was concluded that by their origin and 
behavior, these cells are to be considered a neural crest-like cell population. In another 
species of ascidian, Ciona intestinalis, trunk lateral cells were determined to originate 
near the NPB and migrate out to many different locations in the body (Jeffery et al., 
2008). Interestingly, in this study, it was found that these trunk lateral neural crest-like 
cells expressed homologues to foxd3 and an AP-2 gene suggesting the involvement of 
vertebrate neural crest genes in the specification of these basal cells, however 
homologues to some of the other genes involved in NCC specification and migration 
were not expressed. In the amphioxus Branchiostoma floridae, it was determined that 
homologues of the NPB genes were expressed in the proper place but homologues of 
several of the key genes involved in NCC specification, such as foxd3 and sox10, are 
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found in nearby mesodermal structures, while AP-2 is expressed in the epidermis and 
snail is only expressed in the NPB transiently (Yu, 2010). It is thought that it was not 
until the emergence of true NCCs in vertebrates that these and other neural crest genes 
were recruited to the process of NCC specification and development (Donoghue et al., 
2008). Understanding the gene regulatory network in vertebrate neural crest specification 
will contribute to our understanding of the evolution of NCCs in general and also provide 
clues as to how gene regulatory networks have evolved to add complexity to the already 
existing body plan of more basally derived organisms. 
Significance of the neural crest in human disease 
 NCCs are also very important in human health and development. When there is a 
defect in neural crest development, it can lead to one of many different syndromes and 
phenotypes, collectively known as neurocristopathies (Bolande, 1974). Several human 
neurocristopathies such as Waardenburg syndrome and Hirschsprung disease have been 
linked back to genes involved in the processes of neural crest specification, survival, and 
maintenance (Etchevers et al., 2006). Waardenburg syndrome, which is characterized by 
craniofacial abnormalities, partial to complete hearing loss, and patches of white 
pigmentation on the hair and skin, has been linked to several neural crest-associated 
developmental genes including Sox10, Endothelin 3/Endothelin Receptor B, MITF, and 
Snail2 (Pingault et al., 2010). Hirschprung’s disease, which is characterized by failure of 
the neural crest-derived enteric neurons to properly migrate and colonize the gut resulting 
in aganglionic megacolon, has been linked with the RET oncogene as well Sox10, 
Endothelin signals, and Neuregulin family members (McKeown et al., 2013). Another 
characterized neurocristopathy is DiGeorge syndrome. These patients exhibit many 
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symptoms including craniofacial and heart defects. DiGeorge syndrome is caused by a 
deletion on chromosome 22, a region containing the Tbx1 gene which is involved in 
cardiac and cranial neural crest migration (Vitelli et al., 2002; Moraes et al., 2005; 
Calmont et al., 2009). As these and other neurocristopathies are linked to genetic 
mutations, we can see how important the role of conserved developmental genes is to 
human health. Understanding how these and other genes interact during early neural crest 
development will help us understand how these developmental syndromes arise and 
possibly how they can be screened for and counteracted during human embryonic 
development. 
 Developing NCCs are also an excellent model for metastatic cancer progression. 
Much like NCCs, tumor cells undergo an EMT and break away from the primary tumor 
site, migrate through tissues, and colonize various areas of the body. Many of the 
developmental genes and programs that are used in NCC development, including changes 
in cell adhesion via cadherin expression, breakdown of the ECM via MMPs, and increase 
in cell motility are re-initiated in tumor cells and this often correlates with increased 
metastasis and poor prognosis. Furthermore, there are many cancers that develop from 
neural crest derivatives. These cancers exhibit an even greater similarity with developing 
NCCs, including re-initiation of neural crest associated genes such as the specification 
factor Sox10 and the melanocyte gene MITF. Observing the similarities between these 
processes and using NCC development to understand how they are regulated can be a 





Prdm1a and the PRDM family in development 
 The PRDM family of transcription factors are highly evolutionarily conserved and 
involved in many developmental processes, including neural crest development. PRDM 
proteins primarily regulate gene expression by directly altering histone methylation or by 
recruiting histone-modifying binding partners to target promoters to regulate 
transcriptional activation and repression. There are 16 members of the PRDM family in 
humans. They are characterized by a PR/SET domain which can contain intrinsic 
methyltransferase activity and is also thought to mediate protein-protein interactions as 
well as a DNA interaction domain composed of repeated zinc finger motifs. Enzymatic 
histone methyltransferase activity has only been identified in a few of the members of the 
PRDM family, including Prdm2, Prdm8, Prdm9, and possibly Prdm6 (Hohenauer and 
Moore, 2012). Non-enzymatic PRDM proteins have been known to bind an array of 
partners to mediate their effect on transcription. These include transcriptional repressors 
such as histone methyltransferases (HMTs), histone deacetylaces (HDACs), and protein 
methyltransferases such as Prmt5, as well as transcriptional activators such as histone 
acetyltransferases (HATs).  
 Prdm1, also referred to as Blimp1 in mouse and PRDI-BF1 in human, was one of 
the earliest PRDM proteins to be characterized. Prdm1 has no demonstrated HMT 
activity through its PR/SET domain (Figure 1.2), however it is thought to mediate 
transcriptional regulation through binding partners including HDAC2 (Yu et al., 2000), 
the histone demethylase LSD1 (Su et al., 2009), the HMT G9a (Gyory et al., 2004), and 
the transcriptional co-repressor Groucho (Ren et al., 1999). The role of Prdm1 has been 
studied in many different model organisms and appears to be well conserved. It is 
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required for formation of the endomesoderm in sea urchin and starfish (Livi and 
Davidson, 2006) and anterior endomesoderm in Xenopus and zebrafish (de Souza et al., 
1999; Baxendale et al., 2004; Wilm and Solnica-Krezel, 2005). It is also involved in 
retina formation (Wilm and Solnica-Krezel, 2005; Brzezinski et al., 2010; Katoh et al., 
2010), B-cell development (Turner et al., 1994), muscle development (Baxendale et al., 
2004; Liew et al., 2008) and primordial germ cell specification (Ohinata et al., 2005; 
Vincent et al., 2005), among other roles. It is primarily thought to act as a transcriptional 
repressor, often repressing genes of one cell fate to allow an alternative cell fate to be 
specified. 
 Importantly, Prdm1 is also required for specification of the neural crest. This role 
was discovered through a forward genetic screen to identify factors involved in various 
stages of neural crest development. ENU mutagenesis generated a zebrafish mutant called 
narrowminded, which exhibited loss or reduction of neural crest derivatives including 
pigment cells and craniofacial cartilage (Artinger et al., 1999). This defect was attributed 
 
Figure 1.2. Domains of the Prdm1a transcription factor. 
Schematic showing the major domains of the Prdm1a transcription factor and their 
function and previously identified binding partners. 
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to a decrease in expression of early neural crest specifier genes at the NPB including 
foxd3 and snai1b (snai2) which led to a decrease in the total population of NCCs. The 
narrowminded mutant was mapped to a point mutation in the zebrafish Prdm1 homolog, 
prdm1a (Hernandez-Lagunas et al., 2005). prdm1a is expressed in the developing NPB 
starting at late-gastrulation (90% epiboly) and remaining through neural crest 
specification (2 somites). By 10 somites, prdm1a expression is no longer apparent in the 
NPB, although it remains expressed in the developing adaxial muscle cells. prdm1a 
expression is altered in BMP signaling mutants, suggesting that BMP is a positive 
upstream regulator, however it is unknown if BMP is the only activator of prdm1a 
expression. Morpholino-mediated knockdown of prdm1a recapitulates the narrowminded 
mutant neural crest phenotype while overexpression of prdm1a induces ectopic neural 
crest formation, demonstrating the requirement of prdm1a for neural crest specification. 
Interestingly, in mouse embryos, it is unclear whether the prdm1a homolog plays a role 
in neural crest development. Recent unpublished evidence from our lab suggests that 
another PRDM family member, prdm3, is expressed in the right time and place to be 
involved in this process and due to the homology between PRDM proteins, could take on 
the role of prdm1a in mouse. While it is clear that Prdm1a is regulating the process of 
neural crest formation in zebrafish, it is unknown by what molecular mechanism Prdm1a 
functions in NCCs.  
As Prdm1a is a known transcriptional regulator across many species and cell 
types, I hypothesize that Prdm1a is transcriptionally regulating one or more of the genes 
that are required for neural crest specification within the known gene regulatory network 
of neural crest development. I investigated the role of Prdm1a as a direct activator of 
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neural crest specifiers including foxd3 and tfap2a and to explore its role as both a 
transcriptional activator and repressor during neural crest development. In addition, I 
identify several novel targets of prdm1a regulation that may play roles in disparate 
developmental processes including sensory placode development and neural crest EMT 
and migration. I have demonstrated a novel role for one of these targets, the cell adhesion 
gene cdon, in regulating directed neural crest migration. This work will demonstrate the 
importance of the Prdm1a transcription factor in regulating many processes required for 
neural crest development and embryogenesis and will strive to place Prdm1a within the 


















PRDM1A IS REGULATED BY WNT AND NOTCH SIGNALING AT THE 
 NEURAL PLATE BORDER
1 
Abstract 
 Specification of the neural crest at the neural plate border (NPB) requires a highly 
regulated program of signaling pathways which control gene regulatory cascades within 
the developing cells. It is known that several developmental signaling pathways are 
required for neural crest cells (NCCs) to be induced at the NPB, including the Wnt and 
Notch pathways. What is less clear is how these pathways initiate the expression of 
transcription factors including NPB and neural crest specification factors. Using 
morpholinos, genetic mutants, and drug treatments to perturb canonical Wnt signaling 
and Notch signaling, I determined that prdm1a expression is upregulated within the NPB 
while neural crest specification is inhibited. This suggests that Wnt and Notch signals are 
upstream of the neural crest specification gene prdm1a and may be required to maintain 
prdm1a expression at a level conducive to neural crest specification, yielding evidence of 
a complex system of signaling pathways that tightly regulate expression of factors 
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Wnt signaling is known to be a master regulatory signal in a multitude of 
developmental events in vertebrates. A number of studies have shown canonical Wnt/β-
catenin signaling to play a crucial role in neural crest specification and development in 
zebrafish and other vertebrates. For instance, in mouse, targeted inactivation of β-catenin 
in the dorsal neural tube by Wnt1-Cre-mediated deletion results in defects in the 
formation of cranial and dorsal root ganglia as well as craniofacial elements, suggesting a 
role for β-catenin in cranial neural crest survival and differentiation (Brault et al., 2001). 
In zebrafish, expressing a dominant negative TCF transcription factor that acts as an 
inhibitor of canonical Wnt signaling leads to downregulation of neural crest specifier 
foxd3 during early neural crest specification as well as inhibition of the NCC marker 
sox10 (Lewis et al., 2004). Additionally, morpholino-mediated inhibition of the canonical 
Wnt ligand Wnt8a (Lekven et al., 2001) caused a decrease in expression of neural crest 
markers including foxd3, pax3, and sox10 at the 6 somite stage. In zebrafish, additional 
Wnt ligand genes including wnt1 and wnt3a are expressed in the dorsal neural keel and 
adjacent to the foxd3 expression domain at the 2-somite stage, around the time of neural 
crest specification (Dorsky et al., 1998). In mouse, double knockout mutants of Wnt1 and 
Wnt3a exhibited a loss of neural crest derivatives and neural precursor cells residing in 
the neural tube, suggesting a possibly redundant role for these ligands in specification and 
expansion of premigratory NCCs (Ikeya et al., 1997). Based on expression profiles in 
zebrafish and other model organisms, these and other Wnts including Wnt6, Wnt7b, and 
Wnt10b have been implicated in the induction and specification of NCCs (Wu et al., 
2003), however the extent to which they play a role in the regulation of genes required 
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for neural crest specification, including the prdm1a transcription factor, remains largely 
unexplored. 
Delta/Notch signaling also regulates the specification of neural crest precursor 
cells. Notch receptors are expressed in a broad domain within the neural plate and non-
neural ectoderm, while the delta genes, which encode the Delta ligands for Notch, are 
expressed in primary neuron domains (Appel and Eisen, 1998; Hsiao et al., 2007). In the 
absence of Notch signaling, as occurs in the zebrafish mind bomb (mib) and deltaA 
mutants, there is an excess of all primary neurons, including Rohon Beard (RB) sensory 
neurons and interneurons, and an accompanying reduction in the number of trunk NCCs 
(Jiang et al., 1996; Cornell and Eisen, 2000; Itoh et al., 2003). In Xenopus, 
overexpression of the Notch intracellular domain (NICD), which constitutively activates 
Notch signaling, at the end of gastrulation increases the expression of neural crest 
markers Xslug and foxd3, suggesting that Notch signaling is required for NCC induction 
(Glavic et al., 2004). Blocking Notch with DAPT, a gamma-secretase inhibitor, produces 
a neurogenic phenotype with an increase in the number of primary neurons (Geling et al., 
2002). These findings suggest that lateral inhibition between neurons and NCCs is 
perturbed such that neuronal fate is promoted at the expense of neural crest fate, at least 
in the trunk region (Cornell and Eisen, 2005). Notch signaling is also required for 
neurogenesis within the neural plate itself. As the neural plate domain eventually folds 
into the neural tube, Notch is required in the neural epithelium for the development of 
specific interneuron populations (Mizuguchi et al., 2006; Batista et al., 2008). While 
Notch signaling has a demonstrated role in cell fate specification within neural and neural 
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crest progenitors, it is unclear how Notch might regulate neural crest specification factors 
including prdm1a. 
Materials and methods 
Zebrafish maintenance and lines 
Zebrafish were maintained according to (Westerfield, 1993) and staged by hours 
post fertilization (hpf) and morphology according to (Kimmel et al., 1995). The zebrafish 
prdm1a
m805
, deltaA, and mind bomb mutants have been described previously (Artinger et 
al., 1999; Itoh et al., 2003; Hernandez-Lagunas et al., 2005; Birkholz et al., 2009; Rossi 
et al., 2009).  For single embryos genotyping of deltaA mutants, I used primers and 
protocols provided by ZIRC; mib
m132
 genenotyping is as described in (Itoh et al., 2003). 
Morpholino injections 
wnt8a ATG morpholino, 5’-ACG CAA AAA TCT GGC AAG GGT TCA-3’, was 
injected at the 1-4 cell stage at 9-18 ng. 
Drug treatments 
IWR-1 (Sigma, I0161) stock solution was maintined at 10mg/mL in DMSO. 
Embryos were dechorionated on 1% agar-coated dishes and treated with 0.75-5 μM IWR-
1 in embryo media or 1% DMSO in embryo media from 4-12 hpf. GSK-3 inhibitor 
(Calbiochem) was maintained at 1μM in DMSO. Embryos were treated with 0.2-5 μM 
from 4-12 hpf. Embryos were fixed in 4% PFA for in situ hybridization or stored in 
RNAlater (Ambion) for qRT-PCR. DAPT was maintained at 10μM in DMSO. 100μM, 
200μM, or 1% DMSO in embryo media was applied to embryos at 60% epiboly stage 
with holes poked in the chorions. Embryos were fixed at the tailbud to 2 somite stage in 
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4% PFA at 4⁰C overnight. Chorions were then fully removed and embryos were 
dehydrated in MeOH. 
In situ hybridization 
Whole-mount RNA in situ hybridization (ISH) was performed as previously 
described (Thisse and Thisse, 1998). 
Results 
prdm1a is inhibited by canonical Wnt signaling via wnt8a 
Due to previous work that indicates the role of Wnt8a in the regulation of foxd3 
and other neural crest genes, I investigated whether Wnt8a is also upstream of prdm1a in 
neural crest specification. I injected morpholino (MO) targeting the first open reading 
frame of the zebrafish wnt8a gene (Lekven et al., 2001) into wildtype embryos at the 1 to 
4-cell stage then allowed them to develop to the 2-somite stage. At 2 somites, I fixed a 
portion of the embryos for in situ hybridization for prdm1a or foxd3 expression, and 
isolated RNA from pools of 15-25 of the remaining embryos to perform quantitative RT-
PCR analysis to confirm expression of foxd3 and prdm1a, as well as an additional neural 
crest marker snai1b. In the wnt8a MO-injected embryos, I saw a dose-dependent decrease 
in foxd3 expression, as expected based on previous studies (Lewis et al., 2004). 
Unexpectedly, I saw an increase in prdm1a expression in the NPB and prechordal plate 
regions which was confirmed by qRT-PCR (Figure 2.1). snai1b expression was also 
upregulated in the wnt8a morphants in a dose-dependent fashion. Expression of axin2, 
which is known to be positively regulated by canonical Wnt signaling (Jho et al., 2002), 
was used as a positive control to demonstrate efficacy of Wnt inhibition and demonstrates 
that Wnt8a is primarily functioning as a canonical Wnt ligand as expected. There are also 
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several pharmacological agents available to perturb canonical Wnt signaling in zebrafish 
embryos. IWR-1 is a small-molecule which inhibits Wnt-induced accumulation of β-
catenin by stabilizing levels of Axin2 protein, a component of the β-catenin destruction 
complex (Chen et al., 2009). Upon IWR-1 treatment of embryos from 4-12 hpf, during 
the time of NPB and neural crest induction and specification, I observed a dose-
dependent increase in prdm1a expression within the NPB by in situ hybridization and 
qRT-PCR (Figure 2.2) compared to DMSO-treated control embryos. These data suggest 
that prdm1a is negatively regulated by canonical Wnt signaling and specifically by the 
wnt8a ligand, despite their positive regulatory role in neural crest specification. 
Since knockdown of Wnt signaling during neural crest development results in 
decreased prdm1a expression, I next attempted to constitutively activate canonical Wnt 
signaling using a GSK-3 inhibitor (EMD4Biosciences). This drug inhibits the formation 
of the β-catenin degradation complex by out-competing ATP and binding the ATP-
 
 
Figure 2.1. prdm1a is negatively regulated by wnt8a. 
ISH for prdm1a in wildtype and wnt8a morphant embryos at 2-somite stage (A) 
shows increased prdm1a expression in the absence of wnt8a. qRT-PCR of pooled 2-
somite stage embryos (B) shows dose dependent increase in prdm1a and decreased 




Figure 2.2. Inhibition of canonical Wnt signaling increases prdm1a expression. 
ISH for prdm1a in DMSO treated control and IWR treated embryos at 2-somite stage 
(A, lateral view dorsal to left) shows increased prdm1a expression in decreased 
canonical Wnt signaling. qRT-PCR of pooled 2-somite stage embryos (B) shows dose 
dependent increase in prdm1a and decreased axin2 under IWR treatment, *p<0.05 
compared to DMSO control. 
binding site of GSK-3, preventing its activation and subsequent phosphorylation of β-
catenin, thereby allowing stable β-catenin to accumulate in the cytoplasm and translocate 
into the nucleus to act as a transcriptional co-activator (Atilla-Gokcumen et al., 2006). 
Upon treatment with varying doses of the GSK-3 inhibitor for 8 hours during neural crest 
specification (from 4-12 hpf), I again fixed a portion of the embryos for in situ 
hybridization while isolating RNA from others for qRT-PCR, and analyzed expression 
levels of prdm1a, foxd3, snai1b, and axin2 as a positive control. Interestingly, I observed 
no effect of over-expressing canonical Wnt signaling on the expression of prdm1a 
(Figure 2.3). However, there was a decrease in expression of foxd3 and snai1b. This 
suggests that high levels of Wnt can negatively regulate neural crest specification via 
inhibition of these specifier genes, suggesting a compensatory mechanism to maintain 
proper levels of downstream Wnt targets. It is additionally possible that over-activating 
canonical Wnt signaling has no effect on prdm1a expression because Wnt targeting of 
this gene is already saturated at this stage of development and prdm1a cannot be further 
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inhibited by Wnt signals. Together, these data suggest that appropriate levels of canonical 
Wnt signaling are crucial for proper regulation of prdm1a expression and neural crest 
specification at the NPB. 
prdm1a is downstream of Notch signaling in neural crest and RB cell fate specification 
 Notch signaling plays an important role during generation of cell fate in the 
nervous system and, more specifically, in the fate determination step that defines NCCs. 
In zebrafish Notch mutants and Xenopus embryos in which Notch signaling is 
overexpressed or knocked down, there is an increase in the number of primary neurons at 
the expense of NCCs. Because prdm1a controls the fate of both of these populations, I 
wanted to determine how prdm1a expression is affected by Notch abrogation and explore 
the epistatsis of prdm1a and Notch signaling. First, I examined prdm1a expression in mib 
and deltaA mutants. In mib mutant embryos, which have complete blockage of Notch 
signaling, prdm1a expression was increased throughout the NPB domain and 
 
Figure 2.3. Constitutive activation of canonical Wnt signaling does not affect 
prdm1a. 
qRT-PCR of pooled 2-somite stage embryos shows no change in expression of prdm1a 
upon treatment with varying doses of GSK3 inhibitor. foxd3 and snail2 (snai1b) 
expression is decreased while postivie control gene axin2 is increased demonstrated 
efficacy of drug, p<0.05 compared to DMSO control. 
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significantly expanded in the anterior domain (Figure 2.4). In deltaA mutants, prdm1a 
expression was also increased within this domain but to a lesser degree. As an alternate 
approach to genetically blocking Notch signaling, I also treated wildtype embryos with 
100-200 μm DAPT at 60% epiboly until fixation at the 2-somite stage to inhibit Notch 
signaling specifically during the developmental window when NCCs and RB sensory 
neurons are being specified. I observed an increase in prdm1a expression in the NPB, but 
it was not statistically significant due to variability of treatment penetrance (Figure 2.4). 
It is also possible that inhibition of Notch signaling must occur at earlier developmental 
stages to affect prdm1a expression completely. These results suggest that Notch signaling 
 
Figure 2.4. Notch inhibition increases prdm1a expression at the NPB. 
Lateral views, anterior to the top, dorsal to the right of tailbud and 2 somite stage 
embryos. ISH show prdm1a expression at tailbud in a wildtype embryo (A) and in the 
mib-/- background (B). The overall level of expression is increased and the border 
domain was significantly expanded in mib mutant embryos (white line indicates where 
anterior prdm1a expression was measured using Photoshop; WT average 1.56 
arbitrary pixel units, n=5; mib average 2.01 arbitrary pixel units, n=6; Student’s t-test, 
p=0.03). DMSO control treated wildtype (C) and embryo treated with DAPT, a Notch 
inhibitor (D). prdm1a expression was increased overall when treated from 60% 
epiboly to 2 somite stage with DAPT. 
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negatively regulates prdm1a expression and by doing so increases the progenitor 
population available to produce more neurons. To test this, I performed epistasis 
experiments with Notch and prdm1a. I used DAPT to treat wildtype and prdm1a mutants 
as described. Embryos were examined for NPB markers olig4 and dlx3b, NCCs marked 
by foxd3 expression, and RB sensory neurons by huC expression (Figure 2.5). I 
confirmed that treatment with DAPT in wildtype embryos increased the total number of 
primary neurons, as previously reported (Geling et al., 2002). However, even after 
application of DAPT to prdm1a-/- embryos, I did not observe a rescue in the NPB 
domain marked by a gap in olig4 and dlx3b expression (Figure 2.5, white arrows) or of 
RB sensory neurons in prdm1a mutants (n=39) marked by huC expression at the 2 somite 
stage (Figure 2.5). All DAPT-treated prdm1a mutants (n=27) had foxd3 expression at 
similar levels to wildtype at 2 somite stage, however there was no difference in foxd3 
expressing NCCs between DAPT- and vehicle-treated prdm1a mutant embryos, 
indicating that inhibition of Notch signaling was unable to restore the neural crest 
phenotype observed in prdm1a mutants (Figure 2.5). These results are consistent with 
Notch acting upstream of prdm1a.  
Discussion 
 There is a complex network of signaling pathways that are responsible for 
specifying the NPB and NCCs. Signaling pathways such as Wnt and Notch which are 
known to be upstream of neural crest specification also regulate the expression of prdm1a 
at the developing NPB. When Wnt signaling is inhibited via drug treatment or ligand-
specific morpholinos, prdm1a expression is increased. In addition, prdm1a expression is 




Figure 2.5. Inhibition of Notch signaling cannot rescue the prdm1a mutant 
phenotype. 
Lateral views (A-D) and dorsal views (E-L), anterior to the top of tailbud and 2 somite 
stage embryos. Wildtype embryo showing expression of olig4 and dlx3b (A) and 
prdm1a deficient embryos (B) show no gap in expression of olig4 and dlx3b at tailbud 
stage as observed in wildtype. With the addition of DAPT from 60% epiboly to 
tailbud, wildtype embryos (C) have a slightly wider gap corresponding to the prdm1a 
expression domain, while prdm1a mutant embryos maintain the gap in olig4 and 
dlx3b expression after DAPT treatment (D, arrows). (E, G) Wildtype and prdm1a (F, 
H) mutant embryo at 2 somites; RB sensory neurons shown by the lateral expression 
of huc (arrows) were not recovered in prdm1a-/- embryos following DAPT treatment 
and look similar to DMSO control treated mutants. Wildtype and mutant embryos 
treated with DAPT show anincrease in the overall number of primary neurons (L, I, 
M) as previously reported. (I-L) Similarly foxd3 expressing neural crest cells are not 
increased in prdm1a mutant embryos following DAPT treatment. L, Lateral Rohon-
Beard sensory neurons; I, intermediate interneurons, M, primary motor neurons. 
mutants by blocking Notch signaling with DAPT. Together, these data suggest that Wnt 
and Notch signaling pathways are responsible for regulating cell fate decisions by 
inhibiting prdm1a expression at the NPB while activating other genes such as foxd3 and 
snai1b which are required for specification of NCCs. 
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 Several previous studies have shown that Wnt signaling is required to induce the 
formation of NCCs at the NPB. It is known that when Wnt signaling is perturbed, neural 
crest specification as marked by expression of neural crest specifier genes such as foxd3 
does not properly occur. Interestingly, even though prdm1a is a positive regulator of 
foxd3 and neural crest specification, Wnt signaling has an opposite effect on prdm1a. I 
have demonstrated that Wnt is a negative regulator of prdm1a at the NPB. There are 
several potential mechanisms by which this regulation occurs. It is possible that prdm1a 
is a direct target of canonical Wnt signaling through direct binding of the prdm1a 
promoter by Tcf/Lef transcription factors, which can recruit the Groucho complex of 
repressors. It is also possible that prdm1a is an indirect target of Wnt-mediated 
repression. Wnt signaling may initiate one or more factors which are responsible for 
reducing the expression of prdm1a to maintain the proper domain size for the NPB. It is 
also possible that Wnt acts through one of the neural crest specification genes such as 
foxd3 which, once activated, causes prdm1a to be repressed for the NCC developmental 
program to proceed. As prdm1a expression is turned off in NCCs after specification 
occurs, it is possible that this is mediated through high levels of expression of neural crest 
specifiers such as foxd3 or snai1b, and that reduction of prdm1a at the proper time is 
required for normal NCC development. 
Notch signaling is an important regulator of cell fate in the nervous system 
(Lewis, 1998; Artavanis-Tsakonas et al., 1999; Cornell and Eisen, 2005). Its canonical 
role is in lateral inhibition, where cells with an equivalent developmental potential signal 
to each other and by a stochastic process, one cell becomes a neuron and then inhibits its 
neighbors from becoming neurons. Notch receptors and delta ligands are expressed at the 
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right time and place to be involved in segregation of cell fate between RB sensory 
neurons and NCCs. In mutations that affect Notch signaling in zebrafish, there is an 
excess of all primary neurons, including RB sensory neurons, at the expense of trunk 
NCCs (Jiang et al., 1996; Cornell and Eisen, 2000; Itoh et al., 2003). The transcription 
factors that mediate this process downstream of Notch include olig4 and prdm1a, which 
have been shown to have opposing effects on NPB cell fate specification (Hernandez-
Lagunas et al., 2011). While knockdown of olig4 increases NCCs and RB neurons 
(Filippi et al., 2005), loss of prdm1a reduces both cell fates. Because Notch mediates 
lateral inhibition between these two cell fates, perturbation of Notch signaling results in 
promotion of neuronal fate at the expense of neural crest fate (Cornell and Eisen, 2005). 
Here, I have shown that Notch can regulate prdm1a by normally downregulating its 
expression. This data is the first to support a role for Notch at two time points in zebrafish 
neural development:  1) At early stages, during neural induction, to regulate the number 
of progenitor cells at the NPB and, 2) At a later time point in lateral inhibition to promote 
neuronal fate at the expense of neural crest fate. Interestingly, inhibition of Notch cannot 
rescue any aspect of the prdm1a phenotype, suggesting that prdm1a acts downstream of 
Notch signaling at the NPB. 
 The negative regulation of prdm1a by signaling pathways known to positively 
regulate neural crest specification suggests that while prdm1a is required early at NPB 
for neural crest specifier genes to be expressed, it may later be necessary for the embryo 
to turn down or inhibit prdm1a so that NCCs can develop. Alternatively, it is possible 
that signaling pathways like Wnt and Notch are required to regulate and define the 
expression domain of prdm1a so that it is specifically expressed within a narrow region 
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of the NPB. This adds a layer of complexity to our understanding of how signaling 
pathways are integrated into the gene regulatory network that is required for prdm1a-
























PRDM1A DIRECTLY ACTIVATES FOXD3 AND TFAP2A DURING 




The neural crest comprises multipotent precursor cells that are induced at the 
neural plate border by a series of complex signaling and genetic interactions. Several 
transcription factors, termed neural crest specifiers, are necessary for early neural crest 
development; however, the nature of their interactions and regulation is not well 
understood. Here, I have established that the PR-SET domain containing transcription 
factor Prdm1a is co-expressed with two essential neural crest specifiers, foxd3 and tfap2a, 
at the neural plate border. Through rescue experiments, chromatin-immunoprecipitation 
(ChIP), and reporter constructs, I have determined that Prdm1a directly binds to and 
transcriptionally activates enhancers for foxd3 and tfap2a and that they are functional, 
direct targets of Prdm1a at the neural plate border. Additionally, dominant-activator and 
dominant-repressor Prdm1a constructs suggest that Prdm1a is required both as a 
transcriptional activator and transcriptional repressor for neural crest development. 
Introduction 
Neural crest cells (NCCs) are a transient population of stem cell-like progenitor 
cells that are born at the dorsal neural tube during vertebrate embryonic development. 
NCCs are induced at the junction between neural and non-neural ectoderm in a region 
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called the neural plate border (NPB). The induction of NCCs requires interactions of the 
BMP, Wnt and Fgf signaling pathways. Proper temporal and spatial regulation of these 
genes is required for induction of NPB specifiers, which include members of the pax, 
msx, and dlx gene families, and prdm1a (reviewed in (Aybar and Mayor, 2002; Huang 
and Saint-Jeannet, 2004; Sauka-Spengler and Bronner-Fraser, 2008). After undergoing an 
epithelial-to-mesenchymal transition, NCCs migrate away from the dorsal neural tube 
along specified pathways and differentiate to form one of many derivatives including 
tendons, cartilage and bone of the face, Schwann cells and neurons of the peripheral 
nervous system, and pigment cells. In zebrafish (Danio rerio), the specification of cells at 
the NPB to commit to the neural crest fate occurs at the end of gastrulation and the 
beginning of segmentation around the 2-somite stage. During this process, several key 
genes, referred to as neural crest specifiers, become expressed in the NPB following 
induction of NCCs, including foxd3 (Lister et al., 2006; Montero-Balaguer et al., 2006; 
Stewart et al., 2006), snai1b or slug (Thisse et al., 1995), tfap2a (Barrallo-Gimeno et al., 
2004) and sox10 (Dutton et al., 2001; Carney et al., 2006). Although these neural crest 
specifiers have been well-studied in the context of NCC development, little is known 
about direct interactions among these genes, and how genes that initially pattern the NPB 
interact with and regulate genes required for subsequent NCC specification. 
The Prdm1a transcription factor was identified as an important regulator of neural 
crest in zebrafish when it was reported that embryos carrying a mutation in prdm1a (the 
narrowminded (nrd) and the u-boot (ubo) mutants) exhibit a significant reduction in 
NCCs, marked by downregulation of NCC markers including sox10 and crestin, as well 
as partial loss of derivatives such as pigment cells, craniofacial cartilages, and cranial and 
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dorsal root ganglia (Artinger et al., 1999; Roy and Ng, 2004; Hernandez-Lagunas et al., 
2005; Birkholz et al., 2009). prdm1a is first expressed broadly in the NPB of zebrafish 
embryos at 50% epiboly and continues to be expressed in the developing NPB and 
migrating NCC progenitors, as well as mesodermal adaxial cells, through the 6-somite 
stage (Hernandez-Lagunas et al., 2005). It is also expressed later in the developing 
pharyngeal arches, suggesting an additional role in craniofacial development (Birkholz et 
al., 2009). Interestingly, the expression of prdm1 at the developing NPB is conserved in 
lamprey, the most basal extant vertebrate (Nikitina et al., 2011), suggesting that prdm1 
likely has a conserved role in early NCC development. 
The Prdm1a protein is a transcription factor harboring five zinc-fingers for DNA 
binding as well as a PR/SET domain and Pro/Ser rich region both thought to be important 
in protein-protein interactions (Bikoff et al., 2009). Along with the demonstrated role in 
NCC development, Prdm1a is also necessary for the differentiation of adaxial cells into 
slow-twitch muscle fiber rather than fast-twitch fiber types in zebrafish (Baxendale et al., 
2004; von Hofsten et al., 2008). Consistent with this result, Prdm1a is a key 
transcriptional repressor of fast muscle-specific genes, possibly through both direct and 
indirect methods (von Hofsten et al., 2008; Wang et al., 2011b). The mouse homolog of 
Prdm1a, Blimp-1, is important in the specification of primordial germ cells (Ohinata et 
al., 2005; Vincent et al., 2005), is required for functional differentiation of B and T 
lymphocytes (Turner et al., 1994; Shapiro-Shelef et al., 2003; Shapiro-Shelef et al., 2005; 
Kallies et al., 2006; Martins et al., 2006), and plays a role in the development of the 
forelimb, pharyngeal arches, heart, and sensory vibrissae (Robertson et al., 2007). While 
Blimp-1 likely plays a role in NCC differentiation in the pharyngeal arches, it has not 
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been demonstrated to play a role in mouse NCC specification (John and Garrett-Sinha, 
2009). Several studies on Blimp-1 and its human ortholog, PRDI-BF1, have 
demonstrated that Blimp-1/Prdm1a represses multiple target genes through recruitment of 
various histone modification proteins including histone methyltransferases (Gyory et al., 
2004; Ancelin et al., 2006) and histone deacetylases (Yu et al., 2000) or through binding 
to the Groucho family of co-repressors (Ren et al., 1999). While other members of the 
PRDM family have intrinsic methyltransferase activity through the PR/SET domain 
(Hohenauer and Moore, 2012), it appears that Prdm1 lacks this activity (Gyory et al., 
2004), suggesting that Prdm1-repression or regulation of target genes may depend largely 
on binding partners. 
Several of the genes that are downregulated in zebrafish prdm1a-deficient 
embryos are genes that are involved in neural crest specification at the NPB. One of these 
genes is the forkhead-box transcription factor foxd3. foxd3 is expressed in the NPB and is 
required for formation of NCCs and expression of other NCC specifiers including snai1b 
and sox10 (Montero-Balaguer et al., 2006; Stewart et al., 2006). Studies in chick and 
mouse suggest the role of foxd3 in NCC development is highly conserved (Kos et al., 
2001; Teng et al., 2008) and that foxd3 is required for NCCs to maintain their 
pluripotency (Mundell and Labosky, 2011). Recent work in chick embryos has further 
identified genomic enhancers that drive foxd3 expression specifically in the developing 
neural crest and determined potential transcription factors that bind to and regulate these 
regions (Simoes-Costa et al., 2012), however the direct regulation of foxd3 in zebrafish 
NCCs has not previously been studied. Another gene that is known to be upstream of 
foxd3 in zebrafish is tfap2a, another well-known neural crest specifier. tfap2a is a 
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member of the AP-2 family of transcription factors which play many important roles in 
embryonic development (Brewer et al., 2004; Eckert et al., 2005). Zebrafish tfap2a 
mutants display a loss of neural crest derivatives and a reduction in expression of key 
NCC specifier genes (Knight et al., 2003; Barrallo-Gimeno et al., 2004; Knight et al., 
2004). In double knockdowns of both tfap2a and its redundant family member tfap2c, 
early markers of NCC specification are lost at the NPB including foxd3, snai1b, and 
prdm1a (Li and Cornell, 2007). Further, it has been shown that Tfap2a protein directly 
activates expression of sox10 in zebrafish NCCs (Van Otterloo et al., 2012). Additional 
studies have shown that knockdown of both foxd3 and tfap2a in zebrafish completely 
ablates NCCs and that these genes together are responsible for turning on key signaling 
pathways for neural crest induction (Arduini et al., 2009; Wang et al., 2011a). Despite 
their demonstrated importance in regulating early NCC development, the genes 
responsible for directly regulating tfap2a and foxd3 in the neural crest are unknown. 
Here, I ascertain the Prdm1a gene regulatory network for neural crest 
specification in zebrafish. Via knockdown and mRNA rescue experiments, I show that 
two candidate Prdm1a targets, foxd3 and tfap2a, are able to rescue NCC specification in 
prdm1a knockdown embryos. I demonstrate that Prdm1a binds directly to enhancer 
regions for foxd3 and tfap2a, positively regulating expression of these enhancers at the 
NPB. Thus, Prdm1a is a transcriptional activator of these key neural crest genes, 
revealing for the first time that Prdm1a can act as a transcriptional activator in 
vertebrates. In addition, Prdm1a dominant-activator and dominant-repressor constructs 
must both be present to rescue migratory NCCs in prdm1a-/- embryos. From these data, I 
propose that Prdm1a functions as a transcriptional activator and transcriptional repressor 
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of target genes during development, and that both roles are crucial for formation of the 
neural crest. 
Materials and methods 
Zebrafish maintenance and lines 
Zebrafish were maintained according to Westerfield’s Zebrafish Book 
(Westerfield, 1993). Wildtype (WT) strains include AB, TAB, and EKK lines (ZIRC) and 
mutant lines include prdm1a
m805
 (narrowminded/nrd) (Artinger et al., 1999; Hernandez-
Lagunas et al., 2011), and foxd3
zdf10
 (formerly sym1) (Stewart et al., 2006). 
Developmental staging followed previously published standards (Kimmel et al., 1995). 
All experiments utilizing zebrafish are approved by UC Denver IACUC and conform to 
NIH regulatory standards of care and treatment.  
Morpholino and mRNA injections 
Morpholino oligonucleotides (Gene Tools) were injected at the 1-2 cell stage with 
rhodamine dextran (Molecular Probes). Morpholinos include prdm1a E2I2 splice site 
injected at 4ng (Hernandez-Lagunas et al., 2005), foxd3 5’UTR and ATG morpholino at 
2ng or 4ng each (Montero-Balaguer et al., 2006), tfap2a 5.1 MO at 4ng (Knight et al., 
2003) and tfap2c MO at 5.5ng (Li and Cornell, 2007). mRNA sequences were isolated 
from whole embryo cDNA and cloned into pCS2+ using the following primers: foxd3: 
5’-AAT AAG GAT CCG CCG CCA CCA TGA CCC TGT CTG GAG GCA-3’ and 5’-
GCC GGT CTA GAT CAT TGA GAA GGC CAT TTC GAT AAC GCT G-3’; prdm1a 
(Hernandez-Lagunas et al., 2005). The tfap2a plasmid was a gift from T. Williams. 
mRNA was synthesized using the mMessage mMachine kit (Ambion) and injected at the 
1-cell stage in the following doses: foxd3 at 40pg, tfap2a at 86pg, prdm1a at 75pg, and 
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gfp mRNA at 67pg. mRNA and MOs were co-injected in embryos at the 1-cell stage for 
rescue experiments. 
In situ hybridization 
Whole-mount RNA in situ hybridization (ISH) was performed as previously 
described (Thisse and Thisse, 1998). Single-embryo genotyping of prdm1a-/- following 
ISH was performed as previously described (Rossi et al., 2009). DIG-conjugated 
antisense probes were synthesized from full-length transcript sequences in the pCS2+ 
plasmid to the following genes: snai1b (primers: 5’-GCT AGG GAT CCG CCG CCA 
CCA TGC CAC GCT CAT TTC TTG TCA-3’ and 5’-GAA TTC TAG ATG TGT GTC 
CAC TAG AGC GCC-3’), foxd3 (see above), sox10 (Olesnicky et al., 2010), crestin 
(Rubinstein et al., 2000) and tfap2a (from T. Williams). Fluorescent ISH was performed 
as previously described (Pineda et al., 2006) and used the TSA Biotin System (Perkin 
Elmer NEL700A001KT) followed by Streptavidin Alexa Fluor 488 antibody (Invitrogen 
S11223) to develop FITC-labeled antisense probes and the Sigma Fast Red kit (Sigma 
F4648) to develop DIG-labeled probes. 
Enhancer reporter constructs 
Evolutionarily conserved regions (ECRs) identified on ECR Browser 
(http://ecrbrowser.dcode.org/) containing Prdm1a binding sites identified by 
MatInspector (http://www.genomatix.de) were amplified via PCR from wildtype 
zebrafish genomic DNA using the following primers: foxd3E1: 5’- GGG GAC AAG TTT 
GTA CAA AAA AGC AGG CTA CTG AAC GCT GTG TGT CCA G-3’ and 5’- GGG 
GAC CAC TTT GTA CAA GAA AGC TGG GTA AAT TAT CCA ACT TGG ATG 
AGC G-3’, and tfap2aE2: 5’- GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT 
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ACA TAT GAT CCT TAT GCC ATT CAG-3’ and 5’- GGG GAC CAC TTT GTA CAA 
GAA AGC TGG GTA TGG CAA CTG CAC TAA CCT TCA-3’. Each primer contained 
attB1 (forward primers) or attB2 (reverse primers) sites for gateway cloning into the 
pGreenE vector (from D. Meulemans Medeiros). Plasmid containing the enhancer sites or 
empty plasmid alone, expressing GFP under the cFos minimal promoter, was injected 
into single-cell embryos at 80-100pg. Mutated enhancer sequences were synthesized 
following the QuikChange Site-Directed Mutagenesis kit (Stratagene #200518): foxd3 E1 
Prdm1a binding site (core sequence in bold) GCA AAT GAA AGA GAT CTG C was 
mutated to ATC ACA AAC TGT CGC GAT G and tfap2a E2 TGA AGT GAA TGT 
GTG TAG T was mutated to TTA ACC AGA TCA GCT GTC G. Expression plasmid 
GFP pixel intensity was calculated in Adobe Photoshop by converting images to 
grayscale, normalizing for background auto-fluorescence, outlining each embryo, and 
measuring the average pixel intensity value within the outlined region (using Histogram 
function). 
Chromatin-IP 
Protocol for ChIP on zebrafish embryos was optimized from previously published 
work (Wardle et al., 2006; von Hofsten et al., 2008). The Prdm1a antibody was a 
generous gift from Philip Ingham. ChIP was performed on 2-somite TAB wildtype 
embryos. Approximately 800-1000 embryos were fixed with 1.85% Paraformaldehyde 
for 15 minutes followed by snap freezing. Cells and nuclei were lysed before DNA 
sonication by Bioruptor for 45 minutes to create fragments of ~300bp. Beads incubated 
with Prdm1a antibody, IgG antibody (Jackson Immuno-Research), or without primary 
antibody were added to genomic DNA fragments at 4º C overnight. DNA was eluted 
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from beads at 65º C for 6 hours to overnight and DNA was purified by 
Phenol:Chloroform extraction. qPCR was performed on pull-downs and input DNA using 
Taqman primer/probe sets (Applied Biosystems). 
Activator and repressor constructs 
Prdm1aDBD-VP16 and DBD-EnR fusion constructs were generated as previously 
described (von Hofsten et al., 2008) and cloned into pCS2+. 100-250pg of total mRNA 
from each construct was injected into 1-cell stage embryos. 
Biological replicates and statistics 
All experiments were performed with 3 or more biological replicates. In addition, 
qPCR experiments contained at least 3 technical replicates per biological sample. For 
statistical analysis, ANOVA followed by Fisher’s LSD test was used unless otherwise 
noted. Graphical error bars denote SEM unless stated otherwise. 
Results 
prdm1a is co-expressed with foxd3 and tfap2a at the developing neural plate border 
To determine potential targets for Prdm1a transcriptional regulation, I first 
identified genes that were co-expressed with prdm1a at the NPB during early neural crest 
specification. I used double fluorescent RNA in situ hybridization (ISH) to establish 
expression of prdm1a with known NCC specification genes foxd3 and tfap2a. ISH at the 
2-somite stage showed that both foxd3 and tfap2a are co-expressed with prdm1a within 
an overlapping domain at the NPB (Figure 3.1). prdm1a is expressed throughout the NPB 
while foxd3 is primarily expressed in the anterior NPB at this stage, while tfap2a is 
expressed more broadly throughout the entire NPB. This suggests that foxd3 and tfap2a 
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are good candidates for Prdm1a transcriptional regulation during the initial stages of 
NCC specification. 
foxd3 rescues prdm1a loss-of-function neural crest phenotype 
In prdm1a mutant and morphant zebrafish, it is known that the expression of the 
early neural crest specifier foxd3 is downregulated (Hernandez-Lagunas et al., 2005), and 
in prdm1a-overexpressing embryos, foxd3 is upregulated within the NPB compared to 
wildtype controls. To determine if foxd3 is a candidate for direct regulation by Prdm1a, I 
performed rescue experiments of the prdm1a knockdown neural crest phenotype with 
overexpression of foxd3 mRNA. Wildtype embryos were injected at the single-cell stage 
with either prdm1a-MO alone or co-injected with prdm1a-MO and foxd3 mRNA. 
 
Figure 3.1 prdm1a is co-expressed with foxd3 and tfap2a at the NPB.  
Lateral view confocal micrograph projections of double fluorescent ISH of 2-somite 
(11 hpf) wildtype embryos for prdm1a with foxd3 (A-C) and prdm1a with tfap2a (D-
F). prdm1a (green) is co-expressed with both foxd3 (red, C) and tfap2a (red, F) at the 
NPB, represented by yellow in the merged images (see insets in C and F). All images 
are lateral views with anterior to the top, dorsal to the right. NPB, neural plate border; 
tb, tailbud; *non-specific staining. 
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Embryos were fixed at 2- or 4-somites and whole-mount RNA ISH was performed for 
neural crest markers snai1b and sox10. At 2-somites, snai1b expression is highly 
downregulated at the NPB in prdm1a morphant embryos compared to wildtype (Figure 
3.2; WT= 98% positive for snai1b expression at NPB, prdm1a-MO= 19% express snai1b 
in NPB), similar to what is observed in prdm1a mutants (Artinger et al., 1999). 
Interestingly, snai1b is also downregulated in the mesoderm in both prdm1a morphants 
and mutants, suggesting that prdm1a may also modulate some unknown indirect 
interactions between the NPB and mesodermal tissue. Co-injection of foxd3 mRNA with 
the prdm1a-MO rescued the expression of snai1b at the NPB (87% of embryos), while 
co-injection with gfp mRNA as a negative control did not rescue NPB expression (n=18, 
data not shown). Expression of sox10, another neural crest specifier, is almost completely 
absent in prdm1a morphant embryos (5% of embryos express sox10) and co-injection of 
foxd3 is able to rescue the expression of sox10 at the NPB at the 4 somite stage (Figure 
3.2; prdm1a-MO + foxd3 mRNA= 50% embryos express sox10). The rescue of NCC 
specification with foxd3 mRNA was confirmed in prdm1a-/- embryos (data not shown). 
 Prdm1a directly binds to and activates an enhancer for foxd3 
To determine if foxd3 is a direct target of the Prdm1a transcription factor, I 
searched for the Prdm1a consensus binding sequence, AG(T/C)GAAAG(T/C)(G/T), in 
putative enhancers around the foxd3 locus. ECR Browser (http://ecrbrowser.dcode.org/) 
was used to identify evolutionarily conserved regions (ECRs) between zebrafish, mouse, 
and human that could serve as enhancers for foxd3. The ECR sequences were then 
analyzed using MatInspector (http://www.genomatix.de) to search for conserved 




Figure 3.2. foxd3 mRNA rescues NCCs in  prdm1a-deficient embryos.  
ISH for neural crest markers snai1b (A-C) and sox10 (D-F) on 2-4 somite (11-12 hpf) 
uninjected embryos (A,D), prdm1a morphants (B,E), and prdm1a-MO co-injected 
with foxd3 mRNA (C,F). Dorsal view of wildtype embryos show neural crest 
expression at the NPB (arrows) for both snai1b and sox10, with snai1b also expressed 
in the adaxial cells and mesoderm. In prdm1a-MO embryos, the expression is reduced 
at the NPB. However, after co-injection with foxd3 mRNA, the NPB expression is 
restored. Quantification shown in G, as percent of embryos expressing each marker 
was quantified (n=, snai1b WT=81/84, prdm1a-MO=13/59, rescue=41/48; sox10 
WT=156/160, prdm1a-MO=4/92, rescue=39/77). *p<0.05. All images are dorsal 
view, anterior to the top. NPB, neural plate border; a, adaxial cells; m, mesoderm; 
WT, wildtype. 
consensus binding sequence was identified approximately 5 kb upstream of the foxd3 
start site (foxd3 E1, Figure 3.3). Chromatin immunoprecipiation (ChIP) was performed 
on 2-somite wildtype embryos using a previously published rabbit polyclonal antibody to 
Prdm1a (von Hofsten et al., 2008) and qPCR was performed on the pull-down genomic 
DNA using primers and probe designed to span the putative binding site within foxd3 E1. 
The E1 putative enhancer was enriched in the Prdm1a-bound lysate compared to IgG 
control (Figure 3.3) and no-primary control (data not shown). To confirm the specificity 
of the Prdm1a antibody, I also performed ChIP on 24 hpf embryo lysates and performed 
qPCR using primers and probes against two previously known target enhancers for 





Figure 3.3. Prdm1a directly binds and activates a foxd3 enhancer at the NPB. 
Schematic of the foxd3 locus shows one putative enhancer (E1) approximately 5 kb 
upstream from the foxd3 start site that contains a binding sequence for Prdm1a as well 
as two off-target sites used for ChIP, O1 (8.1 kb upstream of foxd3 start site) and O2 
(2.9 kb upstream of start, A). Prdm1a ChIP pulls down foxd3 E1, enriched compared 
to IgG pulldown (B). Lateral view of embryos injected with empty (no enhancer 
sequence) pGreenE GFP expression vector (C), foxd3 enhancer foxd3E1:GFP (D), 
foxd3E1:GFP with prdm1a-MO (E), and foxd3 enhancer with  mutated Prdm1a 
binding site driving GFP, foxd3mutE1:GFP (F) illustrate specific binding of Prdm1a 
to the foxd3 enhancer E1. Quantification of percent embryos expressing GFP (G; n=, 
foxd3E1:GFP=161/227, foxd3E1:GFP + prdm1a-MO=32/102, 
foxd3mutE1:GFP=29/166) and average pixel intensity of GFP (H, n=10 per 
condition). All images are lateral views, anterior to the top; NPB, neural plate border.  
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(von Hofsten et al., 2008). Both of these enhancers were bound by Prdm1a antibody and 
detected by qPCR (Figure 3.4). qPCR was also performed on four off-target genomic 
regions (Upstream 1 and 2 and Downstream 1 and 2) flanking the highly bound MyHC 
enhancer; Prdm1a did not bind these regions, demonstrating the specificity of the 
antibody (Figure 3.4). I also designed primers and probes to off-target flanking regions of 
foxd3 E1, referred to as foxd3 off-target 1 (O1) and foxd3 off-target 2 (O2). Again, the 
 
Figure 3.4. Controls for ChIP experiment demonstrate specificity of Prdm1a 
antibody.  
Prdm1a pulls down previously identified enhancers for MyHC (A,C) and MyLC (A) 
at 24 hpf and does not pull down genomic regions, Upstream 1 and 2 (U1, -9.9 kb 
from MyHC start site, and U2, -8.4 kb from start) and Downstream 1 and 2 (D1, -6.9 
kb from MyHC start site, and D2, -5.8 kb), flanking the Prdm1a binding site of MyHC 
enhancer (B,C). Prdm1a specifically pulls down foxd3 E1 enhancer and not foxd3 off-
target regions, O1 or O2 (D) and pulls down tfap2a E2 and not the other identified 
enhancers with Prdm1a binding sequences, E1 or E3 (E), at 2-somites. 
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Prdm1a antibody did not pull down the off-target regions, demonstrating that the binding 
of Prdm1a to foxd3 E1 is specific (Figure 3.4). To test whether E1 is a functional 
enhancer for foxd3 at the NPB, I transiently expressed GFP under the control of the entire 
558-bp enhancer in embryos. At 2-somites, the foxd3E1:GFP construct is expressed 
primarily in the NPB in a mosaic pattern (Figure 3.3). Double fluorescent ISH of gfp and 
foxd3 mRNA demonstrates that foxd3E1:GFP, while punctate, is expressed primarily 
where endogenous foxd3 is expressed (Figure 3.5). As expected, the enhancer reporter 
construct does not perfectly mimic the endogenous expression of foxd3 most likely 
because there are several other putative enhancers that likely act to restrict and/or activate 
the expression of foxd3 that are independent of Prdm1a regulation. Following injection of 
prdm1a-MO with the foxd3E1:GFP construct, I observed a severe reduction in enhancer-
 
Figure 3.5. Double fluorescent ISH shows mosaic co-localization of 
enhancer:GFP with endogenous foxd3 and tfap2a mRNA expression.  
Double fluorescent ISH for gfp (A) and foxd3 (B) in foxd3E1:GFP injected embryos 
(A-C, lateral view) and double fluorescent ISH for gfp (D) and tfap2a (E) in 
tfap2aE2:GFP injected embryos (D-F, dorsal view) at 2-somites demonstrate mosaic 
co-localization of enhancer:GFP with the endogenous gene along the NPB (insets in 
C, F). tfap2a and gfp also co-localize in the most anterior NPB in a lateral 




driven GFP expression at the 2-somite stage. This was evident in both the percentage of 
embryos expressing detectable GFP as well as the intensity of GFP expression, measured 
by pixel intensity (Figure 3.3). In addition, I mutated the entire Prdm1a consensus 
binding sequence identified in MatInspector and observed that GFP expression was 
dramatically reduced or absent (Figure 3.3). To confirm that wildtype prdm1a mRNA is 
sufficient to activate the enhancer, I overexpressed prdm1a mRNA with foxd3E1:GFP 
and observed a significant increase in GFP pixel intensity over foxd3E1:GFP-expressing 
embryos (Figure 3.6). Together, these data demonstrate that Prdm1a directly binds to and 
activates an enhancer for foxd3 at the NPB and suggests that this interaction is sufficient 
for specification of the neural crest by foxd3. 
tfap2a is downstream of prdm1a in neural crest specification 
To identify additional candidates for Prdm1a transcriptional regulation, I analyzed 
the expression of other neural crest specifiers in prdm1a morphant embryos by ISH. I 
found that the AP-2 family member tfap2a is downregulated in the NPB of prdm1a 
morphants at 2-somites (Figure 3.7) and is upregulated and expanded in prdm1a-
overexpressing embryos (Figure 3.6) compared to controls. To test if tfap2a is a 
candidate for direct regulation by Prdm1a, I performed rescue experiments with tfap2a 
mRNA in prdm1a morphants, and performed ISH at 2- or 4-somites for foxd3 or sox10, 
respectively. There is a clear downregulation of both foxd3 (Figure 3.8; WT= 88% 
express foxd3 at NPB, prdm1a-MO= 8.5% express foxd3) and sox10 (Figure 3.8; WT= 
81.9% express sox10, prdm1a-MO= 4.7% express sox10) in the prdm1a-MO embryos 
compared to wildtype, and when tfap2a mRNA is co-expressed, both foxd3 and sox10 are 
partially rescued at the NPB (Figure 3.8; foxd3= 40.9% rescued, sox10= 47% rescued).  
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These data suggest that tfap2a is directly downstream of prdm1a in the NCC 
specification pathway and is a candidate for Prdm1a transcriptional regulation.  
Prdm1a directly targets and regulates a tfap2a enhancer 
Three putative enhancers each containing a consensus binding site for Prdm1a 
adjacent to the tfap2a gene locus (Figure 3.9; E1- 2.4 kb upstream of tfap2a start site, E2- 
1 kb downstream of tfap2a gene, and E3- 2.5 kb downstream) were identified as 
described above. ChIP was performed on 2-somite wildtype embryos using the Prdm1a 
antibody, followed by qPCR for each of the putative tfap2a enhancers. Only one putative 
enhancer region, tfap2a E2, was pulled down by the Prdm1a antibody (compared to IgG 
control antibody, Figure 3.9). To show that the 741 bp E2 is a functional enhancer for 
 
Figure 3.6. prdm1a overexpression leads to expansion of foxd3 and tfap2a 
enhancer reporters and endogenous expression. prdm1a mRNA co-injected at the 
single cell stage with foxd3E1:GFP (B,E; n=11) and tfap2aE2:GFP (D,F; n=25) and 
imaged at 2-somites produces increased GFP expression when compared to 
enhancer:GFP constructs alone (A,C). prdm1a mRNA overexpression also increases 
the expression of endogenous foxd3 along the NPB (G,H; dorsal views, n=15) and 




tfap2a at the NPB, I drove GFP transiently under the control of tfap2a E2 and imaged at 
2-somites. GFP expression was seen mostly in the NPB in a broad domain similar to 
endogenous tfap2a expression (Figure 3.9) and double fluorescent ISH shows mosaic co-
 
Figure 3.8. tfap2a mRNA rescues prdm1a-deficient neural crest.  
Dorsal view, anterior to the top, of 2-4 somite uninjected wildtype embryos (A,D), 
prdm1a morphants (B,E), and prdm1a-MO co-injected with tfap2a mRNA (C,F). ISH 
was performed for neural crest markers foxd3 (A-C) and sox10 (D-F). Wildtype 
embryos show defined expression of foxd3 and sox10 at the NPB which is 
significantly decreased in prdm1a-MO embryos. tfap2a mRNA injection rescues the 
neural crest in prdm1a-deficient embryos (C, F). Percent of embryos expressing each 
marker was quantified (G; n=, foxd3 WT=49/58, prdm1a-MO=13/120, rescue=27/72; 
sox10 WT=45/56, prdm1a-MO=3/62, rescue=37/76). *p<0.05. NPB, neural plate 
border; WT, wildtype. 
 
Figure 3.7. tfap2a expression is reduced in prdm1a-MO at the NPB.  
In situ hybridization was performed in uninjected WT embryos (A) and embyros 
injected with prdm1a-MO (B) for tfap2a at the 2 somite stage. Lateral view shows 
decreased tfap2a expression at the NPB in prdm1a morphants. 
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localization of gfp and tfap2a mRNA at the NPB (Figure 3.5), though similar to foxd3, 
tfap2a expression is likely also modulated by other enhancers that are not regulated by 
Prdm1a. I co-injected the tfap2aE2:GFP construct with the prdm1a morpholino and saw 
strong reduction of GFP expression (Figure 3.9). Additionally, I mutated the Prdm1a 
consensus binding site in the tfap2aE2:GFP construct and injected it into single-cell WT 
embryos (tfap2aMutE2:GFP). At 2-somites, GFP expression was reduced to levels 
similar to that of wildtype tfap2aE2:GFP construct in prdm1a knockdown embryos, but 
was not completely ablated (Figure 3.9), suggesting that while Prdm1a is a strong 
regulator of this enhancer, it may not be the only direct activator of tfap2a E2 at the NPB. 
To confirm regulation by prdm1a, I overexpressed prdm1a mRNA with tfap2aE2:GFP 
and observed an increase in GFP pixel intensity compared to tfap2aE2:GFP alone (Figure 
3.6). Altogether, these data indicate that Prdm1a binds to and activates an enhancer for 
tfap2a at the NPB and is sufficient to drive tfap2a specification of NCCs.  
Prdm1a EnR-repressor and VP16-activator constructs directly regulate enhancers for 
foxd3 and tfap2a 
To further investigate Prdm1a regulation of the identified enhancers for foxd3 and 
tfap2a, I created dominant-activator and dominant-repressor constructs for Prdm1a, 
fusing the Prdm1a zinc finger DNA-binding domain (DBD) with either Engrailed (EnR) 
repressor or VP16 activator transcriptional regulation domains. I then co-injected either 
foxd3E1:GFP or tfap2aE2:GFP with prdm1aDBD-EnR and prdm1aDBD-VP16 and 
imaged embryos at 2-somites. I observed a loss of GFP expression in both constructs 
when co-injected with prdm1aDBD-EnR, suggesting that the enhancers were directly 
repressed (Figure 3.10), and an expansion or increase of GFP expression when co-
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expressed with prdm1aDBD-VP16 (Figure 3.10), suggesting that they were directly 
activated in the embryo. These results further demonstrate that Prdm1a directly binds and 
regulates these enhancers at the NPB. 
 
Figure 3.9. Prdm1a directly binds and activates a tfap2a enhancer at the NPB.  
Schematic of the tfap2a locus shows three putative enhancers (E1= 2.4 kb upstream of 
start site, E2= 1 kb downstream, and E3= 2.5 kb downstream) that contain Prdm1a 
binding sequences were analyzed by ChIP (A). Prdm1a ChIP pulls down tfap2a E2, 
enriched compared to IgG (B). 2-somite embryos injected with pGreenE GFP 
expression plasmid (C), tfap2aE2 driving GFP, tfap2aE2:GFP (D), tfap2aE2:GFP 
with prdm1a-MO (E), and tfap2aE2 with a mutated Prdm1a binding site driving GFP, 
tfap2amutE2:GFP (F). Quantification of the percent of embryos expressing GFP (G; 
n=, tfap2aE2:GFP=55/68, tfap2aE2:GFP + prdm1a-MO=43/88, 
tfap2aE2mut:GFP=47/100) and average pixel intensity of GFP (H; n=, 






Figure 3.10. prdm1a dominant-activator, DBD-VP16, and dominant-repressor, 
DBD-EnR, constructs directly regulate foxd3 and tfap2a enhancers.  
Embryos at 2-somite stage expressing foxd3E1:GFP alone (A) or with prdm1aDBD-
EnR (B) or prdm1aDBD-VP16 (C). GFP expression is downregulated when 
foxd3E1:GFP is co-injected with prdm1aDBD-EnR (white asterisks) and upregulated 
when the enhancer construct is co-expressed with prdm1aDBD-VP16. Quantification 
by percent embryos expressing GFP in D (n=, foxd3E1:GFP=19/22, EnR=6/19, 
VP16=28/32) and pixel intensity in E (n=, foxd3E1:GFP=17, EnR=10, VP16=10). 2-
somite embryos expressing tfap2aE2:GFP with prdm1aDBD-EnR also exhibit 
downregulated GFP (G, white asterisks), while when co-expressed with prdm1aDBD-
VP16, display increased GFP expression (H). Quantification by percent GFP-positive 
in I (n=, tfap2aE2:GFP=11/16, EnR=16/36, VP16=36/39) and pixel intensity in J (n=, 
tfap2aE2:GFP=11, EnR=14, VP16=12). *p<0.05. 
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tfap2a and foxd3 form a reciprocal feedback loop with prdm1a at the NPB 
I next explored the genetic hierarchy of these conserved transcription factors 
during neural crest specification. To determine if there are reciprocal interactions 
between prdm1a and its targets, I used morpholinos to knockdown foxd3 and tfap2a and 
assayed for prdm1a expression at the NPB by ISH and qRT-PCR. Interestingly, 
morpholino knockdown of foxd3 caused an increase in prdm1a expression in the NPB at 
the 2-somite stage (Figure 3.11), which was confirmed in foxd3
zdf10/zdf10
 (sym1) mutants 
(data not shown). By ISH, the expression domain of prdm1a is expanded, especially in 
the most anterior region of the NPB where foxd3 is most highly expressed. This suggests  
that foxd3, once activated by prdm1a, restricts the expression of prdm1a in the 
presumptive neural crest; however whether this is a direct interaction is not yet known.  
I next assessed potential regulation of prdm1a by tfap2a. In tfap2a morphants, 
prdm1a expression is unchanged. It is known, however, that in zebrafish NCC 
development, tfap2a shares redundant activity with its family member tfap2c. Upon 
knockdown of both tfap2a and tfap2c, I observed decreased expression of prdm1a, as 
well as foxd3 by qRT-PCR and ISH (Figure 3.11), confirming previously published data 
(Li and Cornell, 2007). tfap2c-MO alone did not decrease expression of foxd3 or prdm1a 
(data not shown). These data suggest a positive feedback loop between prdm1a and 
tfap2a/c during NPB and NCC specification. Interestingly, foxd3 overexpression in 
prdm1a morphants is unable to rescue tfap2a expression at the NPB, proposing a genetic 
hierarchy of NPB and neural crest specifiers in which foxd3 is downstream of both 







Figure 3.11. foxd3 and tfap2a interact reciprocally with prdm1a at the NPB.  
WT embryos (A) and embryos injected with 8 ng foxd3-MO (B) were fixed at 2-
somites and in situ hybridization was performed for prdm1a. Dorsal view of embryos 
shows increased prdm1a expression in foxd3 morphants. Embryos at 2-somites were 
also analyzed for prdm1a expression by qRT-PCR (C), showing a dose-dependent 
increase in prdm1a expression in response to foxd3-MO. In situ hybridization for 
foxd3 (D,E) and prdm1a (F,G) was performed on uninjected WT (D,F) and 
tfap2a/tfap2c double morphant embryos (E,G) at 2-somites. Dorsal views show an 
absence of foxd3 and prdm1a expression at the NPB in tfap2a/tfap2c morphants 
(arrows, E,G). qRT-PCR for prdm1a and foxd3 was also performed on WT and 
tfap2a/c morphants (H) and showed decreased expression of both genes in morphants. 
NPB, neural plate border; a, adaxial cells. *p<0.05. 
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Prdm1a functions as both a transcriptional activator and repressor during neural crest 
development  
My data on the foxd3 and tfap2a enhancers suggest that Prdm1a is a 
transcriptional activator during NCC specification; however, previous work on Prdm1a in 
other cell types and model systems has demonstrated that Prdm1a functions primarily as 
a transcriptional repressor of target genes. Our previously published microarray 
(Olesnicky et al., 2010) as well as mRNA-seq data from embryos at this early stage 
demonstrate both upregulation and downregulation of various genes in prdm1a 
knockdown embryos as compared to wildtype embryos, suggesting that, if these targets 
are direct, Prdm1a may have both transcriptional activator and repressor functions during 
embryogenesis. To demonstrate the mode of Prdm1a transcriptional regulation during 
NCC development, I expressed the prdm1aDBD-VP16 dominant-activator and EnR 
dominant-repressor constructs in prdm1a mutants. In order to ensure the efficacy of these 
constructs during embryonic development, I analyzed their ability to rescue slow twitch 
muscle development in prdm1a-/-, as previously reported (von Hofsten et al., 2008). 
Injection of prdm1aDBD-EnR mRNA partially rescued the slow twitch muscle 
phenotype of prdm1a-/- as assayed by prox1 expression (Figure 3.12). Correspondingly, 
injection of prdm1aDBD-VP16 produced precocious expression of F310 in fast twitch 
muscle (Figure 3.12), demonstrating that each of these constructs is effective at 
regulating established target genes. 
To determine the role of Prdm1a regulation of target genes in neural crest 
development, I injected these constructs into prdm1a mutants and analyzed for NCC 
marker crestin at 24 hpf. In prdm1a-/- embryos, NCCs were highly reduced compared to  
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Figure 3.12. prdm1a DBD-VP16 activating and DBD-EnR repressing constructs 
are functional. 
Injection of prdm1aDBD-EnR construct into prdm1a-/- embryos rescues prox1 
expression in slow twitch muscle (A-C; 10% rescued in C, n=4/20) as shown 
previously (von Hofsten et al., 2008). Injection of prdm1aDBD-VP16 construct into 
wildtype embryos shows precocious expression of F310 (arrows in F) similar to what 
is observed in prdm1a-/- embryos (D-F; 57% exhibit F310 expression shown in F, n= 
47/82). Injection of prdm1aDBD alone into prdm1a-/- embryos does not rescue 
crestin expression in prdm1a mutant embryos (G-I; 100% of prdm1a mutants injected 
with prdm1aDBD alone exhibit reduced neural crest as in I, n=10/10). crestin trunk 
expression in 24 hpf WT/het embryos (J), prdm1a-/- embryos (K), and prdm1a-/- 
embryos rescued with full length prdm1a mRNA (L). 
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wildtype, and in these mutants, I rarely observe NCCs in the anterior trunk or in more 
than 7 somite lengths (Figure 3.13; NCCs in 6% of prdm1a-/- embryos, mutants 
confirmed by single-embryo genotyping). Thus, my criteria for embryos with NCC 
rescue were: 1) the presence of NCCs in the anterior trunk, and 2) instances of NCCs 
migrating in 7 or more somites. In DBD-VP16 or EnR injected mutants, NCCs were 
absent in most embryos (Figure 3.13), suggesting that neither the dominant-activator nor 
the dominant-repressor form of prdm1a is sufficient for NCC development. Injection of 
prdm1aDBD alone also did not rescue NCCs, suggesting transcriptional activation and 
 
Figure 3.13. prdm1a DBD-VP16 and DBD-EnR constructs together rescue NCCs 
in prdm1a mutant embryos. 
Lateral views of wildtype and prdm1a-/- embryos at 24 hpf, dorsal to the top. ISH for 
crestin expression in wildtype and/or heterozygotes exhibit migrating NCCs in the 
trunk (A). prdm1a mutant embryos have little NCC migration and most do not exhibit 
migration in more than 7 somites (B). Injection of prdm1aDBD-VP16 (C) or 
prdm1aDBD-EnR (D) alone cannot rescue NCCs in prdm1a mutants. However, 
injection of prdm1aDBD-VP16 and prdm1aDBD-EnR together rescues crestin 
expression in prdm1a-/- embryos (E), and NCCs of rescued animals are able to 
migrate similarly to wildtype (compare E with A), suggesting that Prdm1a must 
function as both a transcriptional activator and repressor for migratory NCCs to 
develop. prdm1a-/- embryos were identified by curved tail, U-shaped somites and fin 
mesenchyme defects, and confirmed by genotyping. The percentage of embryos with 
NCCs present in 7 or more somites is quantified in F. 
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repression are required for Prdm1a function (Figure 3.12). However, when both the VP16 
and EnR fusion mRNAs were co-injected in prdm1a mutants, NCCs were rescued in 41% 
of mutant embryos (Figure 3.13) to similar levels as seen in prdm1a mRNA rescue of 
prdm1a-/- (Figure 3.12; Hernandez-Lagunas et al., 2005), suggesting that for migratory 
NCC development, Prdm1a is required both as a transcriptional activator and a 
transcriptional repressor.  
 To determine if expression of prdm1aDBD-VP16 and DBD-EnR can rescue 
prdm1a-/- NCCs at earlier stages, I injected DBD-VP16 and DBD-EnR each into 
prdm1a-/- embryos and performed ISH for foxd3 and tfap2a at 2-somites. As expected of 
directly activated targets, foxd3 and tfap2a mRNA expression was rescued by 
prdm1aDBD-VP16 injection in prdm1a-/- while prdm1aDBD-EnR was unable to rescue 
(Figure 3.14). To determine the effect on NCC specification at an intermediate stage of 4-
somites, I assayed for rescue with sox10 in prdm1aDBD-VP16, prdm1aDBD-EnR, and 
prdm1aDBD-VP16 + prdm1aDBD-EnR injected prdm1a mutants. Interestingly, sox10 
expression at the NPB was partially rescued in DBD-VP16 and DBD-EnR alone, as well 
as with both injected together (Figure 3.14). This suggests that Prdm1a regulates sox10  
both by activating genes that positively regulate it, such as tfap2a and foxd3, and 
represses genes that may be repressors of sox10, allowing for its activation by other genes 
that are parallel to the Prdm1a pathway (Figure 3.15). Furthermore, Prdm1a must have 
roles as an activator and repressor of additional targets required for migratory NCCs, as 






These studies demonstrate the role of Prdm1a as a master regulator of neural crest 
specification in zebrafish embryogenesis by directly binding to and activating 
transcription of several hallmark NCC specifier genes. In this study, I have identified   
 
Figure 3.14. prdm1a-dominant activator construct rescues foxd3 and tfap2a in 
prdm1a mutant embryos while both activator and repressor forms rescue sox10.  
Whole-mount ISH was performed on prdm1a-/- embryos injected with prdm1aDBD-
VP16 activator or prdm1a DBD-EnR repressor at 2-somites for foxd3 (A-D, dorsal 
views) and tfap2a (E-H, lateral views). foxd3 and tfap2a are both decreased in 
prdm1a-/- embryos (B, F) compared to WT/het embryos (A,E). Injection of 
prdm1aDBD-VP16 partially rescues foxd3 (C) and expands tfap2a (G) at the NPB in 
prdm1a mutants, while prdm1aDBD-EnR does not rescue either foxd3 or tfap2a 
mRNA expression. ISH was performed on prdm1a-/- embryos injected with 
prdm1aDBD-VP16, prdm1aDBD-EnR, or both combined at 4-somites for sox10 (I-M, 
dorsal views). prdm1aDBD-VP16 (K), prdm1aDBD-EnR (L), and combined DBD-
VP16 with DBD-EnR injection (M) partially rescues sox10 expression in the NPB. 
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foxd3 and tfap2a, both crucial NCC specifiers, as candidate genes downstream of Prdm1a 
during NPB and NCC specification. I have demonstrated that foxd3 and tfap2a co-
localize with prdm1a at the NPB in zebrafish embryos and that prdm1a is both required 
and sufficient to drive their expression at the NPB. Further, both foxd3 and tfap2a rescue 
the reduced NCC phenotype in prdm1a-deficient embryos. I identified Prdm1a consensus 
binding sites in putative enhancers for both of these genes and via ChIP confirmed  
Prdm1a binding at these sites during NCC specification. GFP reporter constructs using 
 
Figure 3.15. Model of Prdm1a gene regulatory network for NCC specification. 
Prdm1a is activated at the NPB by NPB specifiers during gastrulation and epiboly. 
Prdm1a directly activates foxd3 and tfap2a at 2-somites (green arrows) and these 
genes in turn feedback on prdm1a through either direct or indirect mechanisms (black 
arrows). Prdm1a also directly represses genes that are repressors for neural crest 
specification as marked by sox10 at 4-somites (red capped arrow). Additionally, sox10 
expression and NCC specification are likely regulated by other genes that are parallel 
to the Prdm1a pathway of regulation (curved black arrow). Prdm1a also 
transcriptionally activates and represses genes required for the further development of 
NCCs during migratory stages. Green arrows denote direct activation, red arrows 
represent direct repression, and black arrows/caps show activation or repression 
through indirect or unknown mechanisms. GRN, gene regulatory network. 
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these putative enhancers confirmed that they drive expression at the NPB and are directly 
activated by Prdm1a. While these reporter assays demonstrate Prdm1a regulation of these 
specific enhancers, it is important to note that there are other potential enhancers for 
foxd3 and tfap2a that likely also contribute to their regulation at the NPB. These studies 
demonstrate a novel role for Prdm1a as a transcriptional activator of genes required for 
NCC specification and development in zebrafish embryos.  
These data allow me to assemble a new hierarchy of genes that contributes to our 
understanding of the gene regulatory network driving NCC specification (model in 
Figure 3.15). Previous work has shown that tfap2a along with its redundant family 
member tfap2c are upstream of foxd3 (Li and Cornell, 2007), and I have confirmed that 
tfap2a/c also regulate prdm1a through a positive feedback loop within the NPB. The 
subsequent gene cascade for NCC specification is well characterized, with foxd3 and 
tfap2a required for expression of additional early neural crest genes including snai1b and 
sox10. From this work, I now know that Prdm1a, possibly along with other 
transcriptional regulators and/or co-factors, is directly upstream of foxd3 and tfap2a and 
is potentially a master regulator of the initiating steps in specification of NCCs from the 
NPB in addition to potentially regulating specification of the NPB itself (Rossi et al., 
2009). Prdm1a also may have a role in repressing genes that are inhibitors of NCC 
specification and appears to regulate NCCs after initial specification; its action as both a 
transcriptional activator and repressor of genes is required for migratory NCCs. 
These new findings also provide a novel mechanism of Prdm1a transcriptional 
regulation of vertebrate target genes. Previous work on the Prdm1a protein in zebrafish as 
well as its homologs Blimp-1 in mouse and PRDI-BF1 in human have all demonstrated 
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that Prdm1a is a transcriptional repressor of its direct targets. In zebrafish muscle cells, 
Prdm1a binds to and represses sox6, a repressor of slow-twitch muscle genes, and may 
also target fast-twitch fiber genes in order to promote slow muscle differentiation (von 
Hofsten et al., 2008). In mammalian B cells, Blimp-1 is considered a master regulator of 
plasma cell differentiation as it directly represses several genes associated with the 
mature B cell program and cell cycle. Specifically, Blimp-1 recruits HDAC enzymes to 
repress transcription from the c-myc (Yu et al., 2000) and Pax-5 (Lin et al., 2002) 
promoters. Additionally, Blimp-1 represses expression of the interferon-β gene by 
interacting with both the Groucho family of transcriptional co-repressors as well as G9a 
methyltransferase (Ren et al., 1999; Gyory et al., 2004). Interestingly, the Pro/Ser rich 
region as well as the zinc-finger domain of Blimp-1 seems to be responsible for 
interaction with each of these transcription co-factors. This, combined with the fact that 
Blimp-1/Prdm1a does not appear to have any intrinsic histone methyltransferase activity 
through its PR/SET domain, suggests that Prdm1a regulates targets primarily through the 
recruitment of binding partners. 
In contrast to published reports, my new findings indicate that in zebrafish NCC 
specification, Prdm1a also has transcriptional activator function; it binds and activates 
transcription of foxd3, tfap2a, and potentially other genes as well. Additionally, the 
results from the super-activator and super-repressor experiments suggest that Prdm1a is 
required to act as both a transcriptional activator and repressor to drive development of 
NCCs. The question of how this dual function works in the embryo remains; it is unclear 
if Prdm1a performs these roles differently in different cells types, at different 
developmental stages, or on specific targets. The Prdm1a protein contains several 
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potential protein-protein interaction domains, which suggest that different transcriptional 
co-factor binding partners may help facilitate the switch in Prdm1a regulation. As 
Prdm1a has not been shown to have any intrinsic transcriptional regulation abilities, it 
stands to reason that these additional co-factors are required to mediate Prdm1a-
regulation of target genes. I hypothesize that Prdm1a acts as a transcriptional repressor 
during NPB stages to repress neural plate and non-neural ectoderm from expanding into 
the NPB, thus specifying the neural crest domain. One candidate for Prdm1a 
transcriptional repression is olig4, a transcription factor expressed within the interneuron 
domain of the neural plate, which is upregulated in prdm1a morphants and is known to 
repress NPB and NCC fates (Hernandez-Lagunas et al., 2011). Once the NPB is 
specified, Prdm1a then activates neural crest specifiers foxd3, tfap2a, and others to 
promote the NCC fate. At the same time, foxd3 likely represses prdm1a from the NPB, 
potentially to maintain and specify the fate of the NCCs from the NPB. Prdm1a also 
appears to activate and repress genes required for NCC migration, such as adhesion and 
EMT genes, possibly regulating their expression during initial neural crest specification 
(Figure 3.15). 
Prdm1a is highly-conserved in vertebrates and some echinoderms (Davidson et 
al., 2002a; Hinman and Davidson, 2003; John and Garrett-Sinha, 2009), especially within 
the key PR/SET and zinc-finger domains (Nikitina et al., 2011). In the basal vertebrate 
lamprey, prdm1 is expressed in the developing NPB and is regulated by several NPB 
regulators including Msx-1 and AP-2. In zebrafish, prdm1a expression is also dependent 
on two AP-2 family members, tfap2a and tfap2c (Li and Cornell, 2007), and here I now 
demonstrate a positive reciprocal interaction where Prdm1a in turn directly activates 
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tfap2a at the NPB. Interestingly, in the echinoderm sea urchin, the prdm1 homolog 
blimp1 (also known as Krox1) is important in specifying the endomesoderm through the 
Wnt8 pathway, and directly activates both the Wnt8 and Otx genes, rather than acting as a 
transcriptional repressor (Davidson et al., 2002a; Davidson et al., 2002b; Hinman and 
Davidson, 2003; Minokawa et al., 2005). Additional targets within the endoderm include 
eve and hox11/13b, which also appear to be transcriptionally activated by blimp1 (Livi 
and Davidson, 2006). In addition to its demonstrated role as an activator of genes in the 
endoderm, blimp1 represses its own expression in the mesoderm, likely through direct 
binding (Livi and Davidson, 2006), and directly represses the delta-repressor HesC 
within the nonskeletogenic mesoderm (Smith and Davidson, 2008). This combination of 
roles for blimp1/prdm1 within different tissue types in the sea urchin embryo suggests an 
evolutionarily conserved ability for prdm1 to function as both a transcriptional activator 
and repressor during embryonic development, and further supports the role for prdm1 as 
a master regulator of developmental pathways. 
In vertebrate embryos, prdm1 is expressed in the NPB in Xenopus and 
knockdown of prdm1 causes malformation of the head, potentially due to NCC defects 
(de Souza et al., 1999). In addition, prdm1 is induced at an ectopic NPB following neural 
plate grafts into the non-neural ectoderm (Rossi et al., 2008), however the exact role of 
prdm1 in Xenopus NCC development is unclear. In mouse, prdm1 does not appear to 
have a role in neural crest specification directly, but does play a role in craniofacial 
development (Vincent et al., 2005), suggesting that its role in early NCC development 
may not be conserved in mammals. However, I have recently determined that the prdm1 
family member, prdm3, is expressed in migratory NCCs in the mouse embryo and thus 
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may have assumed the role of prdm1 in early NCC development in mammals 
(unpublished data). Interestingly, prdm3 is also important for cranial NCC maintenance 
in zebrafish (Ding et al., 2013) and is expressed in cranial NCCs in Xenopus (Mead et al., 
2005). 
In conclusion, these studies demonstrate a novel role for Prdm1a as a 
transcriptional activator of the gene regulatory network required for neural crest 
specification in zebrafish and suggest that Prdm1a functions as both a transcriptional 
activator and transcriptional repressor of multiple targets in different tissues and 


















WHOLE-GENOME AND TRANSCRIPTOME APPROACHES TO 
DISCOVERING NOVEL TARGETS OF PRDM1A 
Abstract 
 Prdm1a is known to be required for neural crest specification and development. It 
is required to transcriptionally activate several neural crest specifier genes at the neural 
plate border and recent evidence suggests that it also functions as a transcriptional 
repressor in neural crest development. The downstream targets of this multi-functional 
gene throughout embryonic development are still unclear. Utilizing exciting new 
techniques for the zebrafish model system, I have identified several new targets for 
Prdm1a regulation during development. I have combined Chromatin-Immunopreciptation 
deep sequencing (ChIP-seq) and RNA deep sequencing (RNA-seq) to discover novel 
direct, functional targets of Prdm1a during the period of neural crest specification. These 
targets include genes involved in placodal development, EMT, and cell adhesion and 
migration, which make them intriguing targets with potential to be involved in neural 
crest development.  
Introduction  
I have previously shown that the Prdm1a transcription factor has a complex role 
as a master regulator of neural crest specification and acts as a transcriptional activator of 
neural crest specifier genes including foxd3 and tfap2a and is additionally required as a 
transcriptional repressor for specified NCCs to reach the migratory stage (Powell et al., 
2013). While it is clear the Prdm1a is required in a complex gene regulatory network, it is 
yet unknown what additional genes it regulates both directly and indirectly during NCC 
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development. To determine what some of these downstream factors might be, I decided 
to use an unbiased approach that would allow me to identify novel targets. With the 
availability of high-throughput sequencing and our previous success with Prdm1a ChIP 
in zebrafish embryos, I determined that ChIP-seq would allow me to identify novel direct 
targets of Prdm1a. In addition, to determine novel functional targets that are regulated by 
Prdm1a, I determined to use mRNA-seq to compare wildtype and prdm1a-deficient 
embryos. Using these data together, I discovered several novel targets of prdm1a 
including genes involved in the specification of sensory placodes which develop adjacent 
to the neural crest and which interact with each other during development (Theveneau et 
al., 2013). I also discovered several targets involved in cell adhesion, EMT, and motility, 
which were of great interest as they may be involved in these processes leading up to 
NCC migration. The extent of genes whose expression is regulated by prdm1a either 
directly or indirectly yield further evidence that prdm1a is a master regulator of several 
processes required for NPB and neural crest specification and development and plays a 
key role in this embryonic gene regulatory network. 
Materials and methods 
ChIP-seq 
Chromatin-IP was performed on 2-somite stage wildtype embryos using the 
Prdm1a antibody as previously published (Powell et al., 2013). Purified DNA from 2 
biological replicates each of Prdm1a pull-down and input was sequenced at the 
University of Colorado Denver Genomics and Microarray Core using an Illumina 1x50 
platform. Bioinformatic analysis was performed at the University of Colorado Cancer 
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Center. Reads were aligned using Novoalign to danRer7 genome build. Peaks were called 
with MACS at q < 0.05. 
RNA-seq 
mRNA was isolated from 2-somite stage wildtype and prdm1a morpholino 
injected embryos using the RNeasy purification kit (Qiagen). Approximately 15-20 
embryos from each condition were pooled. Illumina 2x100 RNA deep sequencing was 
performed at the University of Colorado BioFrontiers Institute. Bioinformatic analysis 
was performed at the University of Colorado Cancer Center. 
Morpholino injections 
prdm1a (E2I2) morpholino was injected as previously described (Hernandez-
Lagunas et al., 2005). 
In situ hybridization 
Whole-mount RNA in situ hybridization (ISH) was performed as previously 
described (Thisse and Thisse, 1998) using previously published probes: kctd15a (Dutta 
and Dawid, 2010), six1b, eya1, eya2 (gifts from H. Ford lab); and probes cloned into 
TOPO from wildtype zebrafish cDNA: midn, pmp22a, scube3, itgb1b. 
Results 
ChIP-seq and RNA-seq yield several novel targets of Prdm1a 
 Several genes were identified using ChIP-seq and RNA-seq methods. ChIP-seq 
using the Prdm1a antibody identified 103 genes bound by Prdm1a at the 2-somite stage. 
RNA-seq comparing wildtype and prdm1a morphant embryos at the same stage 
identified 2,557 genes differentially regulated more than 1.3 fold in the knockdown. 
Several genes already identified as targets of Prdm1a regulation were identified in both 
67 
 
the ChIP-seq and RNA-seq, demonstrating the efficacy of both techniques. ChIP-seq 
identified the binding of Prdm1a to foxd3 in both biological replicates (Figure 4.1) and 
tfap2a in one of the replicates, confirming previous data (Powell et al., 2013). RNA-seq 
confirmed the positive regulation of neural crest specifiers foxd3, tfap2a/c, sox10, and 
snai1b, and the negative regulation of the interneuron gene olig4 (Hernandez-Lagunas et 
al., 2011). Novel prdm1a target genes of interest were identified from the ChIP-seq and 
RNA-seq datasets by comparing their gene expression published on the zebrafish 
database ZFIN (zfin.org) and through available literature. RNA-seq was performed in 
duplicate, preventing analysis of statistical significance, however target genes were 
filtered by having an FPKM (fragments per kilobase per million) greater than 5 and a fold 
of 1.3 change up- or downregulation. 
ChIP-seq identified several novel direct Prdm1a targets (Table 1, Appendix A). 
As my previous data suggests that Prdm1a inhibits specification of neighboring domains 
while activating neural crest gene expression within the NPB, I looked for targets that 
were expressed within the neural plate, NPB, and non-neural ectoderm or genes whose  
Table 1. Putative direct targets of Prdm1a identified by ChIP-seq. 
Gene 






Fold Change in 
RNA-seq 
(prdm1a MO) 
foxd3 ENSDARG00000021032 chr6:31791268 -5268 -3.70 
runx3 ENSDARG00000052826 chr13:45775414 121 Below threshold 
neurog1 ENSDARG00000056130 chr14:27713098 668 -1.18 
itgb1b ENSDARG00000053255 chr2:46188008 -85555 1.21 
midn ENSDARG00000018524 chr22:18894259 76336 -1.51 
scube3 ENSDARG00000011490 chr23:41766084 -63926 Below threshold 
elavl3 ENSDARG00000014420 chr3:46942840 -86871 Not detected 
pmp22a ENSDARG00000032724 chr3:48092797 34602 1.41 
wnt7aa ENSDARG00000044827 chr11:28282270 80910 Below threshold 
nog2 ENSDARG00000043066 chr24:40367831 38010 Below threshold 
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These include itgb1b (Figure 4.1), a member of the beta-1 integrin family of proteins 
which are thought to modulate migration of many cell types including NCCs (Breau et 
al., 2006), midnolin (midn, Figure 4.2), a nucleolar protein which is expressed in the NPB 
(Tsukahara et al., 2000), scube3 which is expressed in mouse brain and is involved in 
Hedgehog signaling (Haworth et al., 2007; Johnson et al., 2012; Xavier et al., 2013), and 
peripheral myelin protein 22a (pmp22a) which is expressed in the neural crest derivative 
 
Figure 4.1. ChIP-seq peaks show Prdm1a binding sites near foxd3 and itgb1b. 
Prdm1a ChIP-seq peaks (blue) adjacent to target genes of interest (purple boxes) foxd3 
and itgb1b aligned to UCSC browser. Red arrows denote called peaks. Conservation 





Schwann cells (Sancho et al., 2001). To confirm the regulation of these genes by prdm1a, 
I performed in situ hybridization in wildtype and prdm1a morphant embryos at 2 somites. 
I found that itgb1b, midn, and pmp22a were expressed in the NPB and are downregulated 
there in the absence of prdm1a (Figure 4.3). scube3 is expressed diffusely throughout the 
 
Figure 4.2. ChIP-seq peaks show novel Prdm1a binding sites near midn, scube3 
and pmp22a. 
Prdm1a ChIP-seq peaks (blue) adjacent to target genes of interest (purple boxes) midn, 
scube3 (B), and pmp22a aligned to UCSC browser. Red arrows denote called peaks. 
Conservation to mammals shown in dark blue (PhyloP). 
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embryo, however it is also downregulated in prdm1a morphants. As little is known about 
the roles of these genes, especially in neural crest development, they are excellent 
candidates for future study in Prdm1a-mediated regulation during neural crest 
specification. Additionally, some of the targets identified by ChIP-seq are genes that have 
known roles in Rohon-Beard sensory neuron development, including runx3 and 
neurogenin1 (neurog1), further supporting the known role of Prdm1a as a regulator of 
Rohon-Beard cells in addition to NCCs (Rossi et al., 2009; Olesnicky et al., 2010; Park 
and Saint-Jeannet, 2010).  
 The RNA-seq dataset identified many genes regulated by prdm1a, demonstrating 
its role as a master regulator of a vast array of programs in the development of neural 
crest and other cell types (Table 2, Appendix B). Several of the genes identified as 
downregulated were genes expressed in the NPB that are known to be important in the  
 
Figure 4.3. prdm1a regulates targets identified by ChIP-seq at 2 somites. 
ISH for putative Prdm1a targets identified by ChIP-seq at 2 somites comparing 
wildtype to prdm1a morphant embryos. pmp22a, scube3, itgb1b, and midnolin are all 
downregulated in the absence of prdm1a, suggesting they are functional targets. 
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Table 2. Genes of interest identified by RNA-seq as regulated by prdm1a. 
Gene Name Ensembl ID Fold Change 
(prdm1a MO) 
Known targets   
sox10 ENSDARG00000077467 -6.93 
foxd3 ENSDARG00000021032 -3.70 
snai2 ENSDARG00000040046 -1.62 
tfap2a ENSDARG00000059279 -1.55 
tfap2c ENSDARG00000040606 -1.28 
olig4 ENSDARG00000052610 2.27 
NPB/NCC genes   
dlx3b ENSDARG00000014626 -1.61 
dlx4b ENSDARG00000071560 -5.38 
msxb ENSDARG00000008886 -1.11 
msxc ENSDARG00000015674 -2.06 
msxe ENSDARG00000007641 -1.25 
zic2b ENSDARG00000037178 -1.16 
zic5 ENSDARG00000016022 -2.73 
kctd15a ENSDARG00000045893 -2.11 
Wnt/Notch signaling   
dla ENSDARG00000010791 -1.43 
dlb ENSDARG00000004232 -2.12 
dld ENSDARG00000020219 -1.99 
wnt10b ENSDARG00000040925 -1.54 
wnt8b ENSDARG00000006911 -1.35 
sfrp1a ENSDARG00000035521 1.95 
Placodal genes   
eya1 ENSDARG00000014259 -2.05 
eya2 ENSDARG00000018984 -1.13 
six1b ENSDARG00000026473 -1.55 
EMT/migration   
cdh11 ENSDARG00000021442 1.89 
cdh6 ENSDARG00000014522 1.96 
rac1 ENSDARG00000094613 15.26 
rhov ENSDARG00000070434 1.34 
rnd3a ENSDARG00000076799 2.60 
rock2 ENSDARG00000087746 4.94 
mmp2 ENSDARG00000017676 10.06 




specification of the border from the neural plate. These include genes of the msx and dlx 
families. Interestingly, prdm1a also appears to regulate genes involved in the Wnt and 
Notch signaling pathways including delta and wnt ligands, suggesting that there may be a  
regulatory loop established in which Prdm1a regulates these pathways which in turn 
regulate prdm1a expression. Several genes were selected for confirmation by in situ 
hybridization based on known expression pattern or previously identified roles in neural 
crest development or pathways that might contribute to neural crest development. These 
genes include kctd15a which inhibits neural crest specification (Dutta and Dawid, 2010; 
Zarelli and Dawid, 2013) and sfrp1a which is an inhibitor of canonical Wnt signaling 
(Pezeron et al., 2006; Kim et al., 2007). I performed in situ hybridization on wildtype and 
prdm1a morphant embryos at 2 somites and found that kctd15a appears to be 
 
Figure 4.4. prdm1a regulates kctd15a as identified by RNA-seq. 
ISH of targets identified by RNA-seq as potentially regulated by prdm1a. kctd15a is 
downregulated at the NPB of prdm1a morphants at 2 somites. sfrp1a does not appear 
to be regulated by prdm1a. 
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downregulated in prdm1a morphants at the NPB (Figure 4.4). sfrp1a, however, is more 
broadly expressed and it is unclear by in situ hybridization if it is regulated by prdm1a. 
These novel targets of prdm1a suggest an expanded role for prdm1a in regulating genes 
involved in neural crest specification and development.  
prdm1a regulates placodal genes 
 One interesting set of genes that were identified as regulated by prdm1a in the 
RNA-seq dataset were a group of transcription factors that are required for sensory 
placode development. Cranial sensory placodes are ectodermal in origin and give rise to 
sensory neurons and ganglia of the head. As the sensory placode is specified adjacent and 
just lateral to the neural crest, it is interesting to hypothesize that its development might 
also be regulated by prdm1a. Placode specification genes six1b, eya1, and eya2 (Zou et 
 
Figure 4.5. Placodal genes are positively regulated by prdm1a. 




al., 2004; Kozlowski et al., 2005; Ikeda et al., 2007; Christophorou et al., 2009) were all 
found to be downregulated in prdm1a morphants by RNA-seq (Table 2). I performed in 
situ hybridization to confirm the regulation of six1b, eya1, and eya2 by prdm1a. prdm1a 
morphants, when compared to wildtype, exhibit a decrease in all three of these genes in 
the developing placode at 2 somites (Figure 4.5). As none of these genes were identified 
on the ChIP-seq, this regulation is most likely indirect, suggesting tissue-tissue 
interactions between the placode and NCCs. Alternatively, as prdm1a is expressed 
overlapping yet slightly lateral to neural crest specifiers such as foxd3, it is possible that 
prdm1a is also expressed in the developing placode and regulates these genes indirectly 
within the placodal cells themselves. 
prdm1a regulates known EMT and migration genes 
 After specification, NCCs undergo an EMT event in order to migrate. It is 
possible that, in addition to regulating neural crest specifiers, prdm1a also contributes to 
the regulation of genes required in EMT. Several genes that are involved in cell adhesion, 
motility, and polarity were identified in the RNA-seq (Table 2). cadherin6 and 
cadherin11 are members of the cadherin family of adherens junction proteins and have 
demonstrated roles in neural crest migration in chick and Xenopus, respectively (Vallin et 
al., 1998; Coles et al., 2007; Taneyhill et al., 2007; Kashef et al., 2009). They are both 
upregulated in prdm1a morphants suggesting that prdm1a negatively regulates their 
expression. Rac and Rho proteins are involved in cell polarity during directed cell 
migration of many cell types including NCCs (Liu and Jessell, 1998; Groysman et al., 
2008; Shoval and Kalcheim, 2012; Clay and Halloran, 2013). In prdm1a morphants, 
several of these genes are upregulated including rac1, rhov, the Rho GTPase rnd3a, and 
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the Rho kinase rock2. This suggests a novel role for prdm1a in NCC polarity which could 
contribute to directed neural crest migration. Matrix metalloproteinases (MMPs) are also 
involved in breaking down basement cell membrane and ECM so NCCs can migrate. 
mmp2 which has a demonstrated role in chick NCC migration (Cai et al., 2000; Duong 
and Erickson, 2004; Anderson, 2010) was found to be upregulated by prdm1a while 
another MMP gene, mmp15 which has a role in endothelial cell EMT (Tao et al., 2011) 
and is expressed in chick neural folds (Patterson et al., 2013) was downregulated. These 
data suggest that prdm1a, in addition to its role as an activator of neural crest 
specification, regulates genes required for EMT and migration of the neural crest. 
Discussion 
 Together, these studies demonstrate the role of Prdm1a as a master regulator of 
the gene regulatory network required for not only neural crest specification, but also for 
surrounding tissues such as the developing sensory placodes, and for further neural crest 
developmental programs such as EMT and migration. Using the unbiased approaches of 
ChIP-seq and RNA-seq, I am able to understand more globally the effects of Prdm1a 
transcriptional regulation within the embryo. These datasets provide clues not only to 
how Prdm1a functions within the developing neural crest, but also how tissues interact 
during development. They also suggest a role for genes that are specifically expressed in 
the NPB in setting up genetic programs for migration and differentiation that will take 
effect much later in development. This suggests that programs required for neural crest 
migration such as adhesion and polarity changes are actually initiated or regulated much 
earlier in development than previously thought. 
76 
 
 Several novel targets of Prdm1a regulation were identified using the methods of 
ChIP-seq and RNA-seq. I have confirmed the expression and regulation by prdm1a at the 
NPB of some of these targets. They include midn, pmp22a, itgb1b, and kctd15a. Several 
of these genes have never been identified as having a role at the NPB or in NCCs. midn 
encodes a fairly novel nucleolar protein which is expressed in the mouse mesencephalon 
and pancreas and contains a ubiquitin-like domain (Tsukahara et al., 2000; Hofmeister-
Brix et al., 2013). Very little is known about the role of nucleolar proteins in neural crest 
development, however one nucleolar protein, Treacle, has been identified as being 
involved in mouse NCC development and the mouse mutant of this protein is a model of 
the human neurocristopathy Treacher Collins syndrome (Jones et al., 2008; Sakai and 
Trainor, 2009). This suggests an interesting new avenue for the study of nucleolar 
proteins in neural crest development. pmp22a is another unknown player in neural crest 
development. Mutation and overexpression of PMP22 is associated with the 
demyelinating disease, Charot-Marie-Tooth disease (Koros et al., 2013; Li et al., 2013). 
Schwann cells, the myelinating cells of the peripheral nervous system, are derived from 
the neural crest. Little is known about the role of PMP22, although it does appear to 
function partly through the regulation of cell-cell junctions in peripheral nerves (Guo et 
al., 2013). The expression of pmp22a at the NPB and regulation by prdm1a suggests a 
novel role for this gene in early neural crest development, well prior to Schwann cell 
differentiation. Prdm1a also directly targets itgb1b, a member of the beta-1 integrin 
family which has been linked to enteric neural crest migration downstream of the neural 
crest transcription factor, Sox10 (Breau et al., 2006; Watanabe et al., 2013), and motility 
of NCCs on the ECM protein, fibronectin (Strachan and Condic, 2008). This 
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demonstrates a potential role for itgb1b in setting up EMT and migration early at the 
NPB.  
Another novel target of prdm1a regulation is kctd15a, which has been 
demonstrated to inhibit neural crest formation by attenuating canonical Wnt signaling and 
by directly binding and inhibiting the TFAP2-α transcription factor which is required for 
neural crest specification (Dutta and Dawid, 2010; Zarelli and Dawid, 2013). It is 
therefore somewhat surprising that prdm1a appears to be a positive regulator of kctd15a. 
It is speculated that kctd15a is required to limit the domain of neural crest specification, 
thereby allowing surrounding tissues to form. It is interesting to note that both Wnt 
signaling and the foxd3 transcription factor, positive regulators of neural crest 
specification, also downregulate prdm1a expression at the NPB, suggesting that too much 
or prolonged expression of prdm1a might inhibit neural crest. It is possible that prdm1a 
positively regulates kctd15a to help limit and refine the expression domain for NCCs. 
Interestingly, Prdm1a also directly targets genes that are expressed in Rohon-Beard 
neurons, a cell type that is also specified at the NPB from the same tissues that will 
specify the NCCs. prdm1a mutants display a lack of Rohon-Beard cells along with 
reduced NCCs. These data suggest that Prdm1a directly regulates both NCC and Rohon-
Beard neuron specification and indirectly regulates several genetic programs that further 
contribute to the specification and further development of these cell types. 
 One of the interesting and unexpected programs regulated by Prdm1a is a cohort 
of genes required for sensory placode development. Prdm1a is a positive upstream 
regulator of several transcription factors required for placode development, including six1 
and eya1/2. It appears that this regulation is indirect, suggesting a non-cell autonomous 
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interaction between neural crest and placodal tissues during development. Interestingly, 
recent work from the Mayor lab has demonstrated an interaction between the cranial 
neural crest and placodes during neural crest migration involving physical chemotaxis 
between the tissues (Theveneau et al., 2013). It is possible, therefore, that in addition to 
regulating neural crest development, prdm1a also contributes to the regulation of sensory 
placodes to ensure that these tissues are able to develop and interact with one another for 
proper migration of a subset of the NCCs. Whether this regulation occurs through non-
cell autonomous signaling from prdm1a-expressing cells within the NPB or if part of the 
prdm1a expression domain encompasses some or all of these developing placodal cells is 
yet undiscovered. 
 Prdm1a also regulates several genes known to have a role in EMT and migration 
of NCCs and other cell types. These include adhesion genes such as the cadherin proteins 
whose regulation is required for proper NCC delamination and migration, Rho/ROCK 
members which are involved in regulating cell polarity during directed cell migration, 
and MMPs which break down the ECM and basement membrane for NCCs to migrate. 
Some of these genes are upregulated in the absence of prdm1a, suggesting that prdm1a 
could be involved in keeping their expression low during neural crest specification and 
upon its downregulation, these genes are upregulated at the proper time. Other genes 
involved in these processes are downregulated in response to prdm1a morpholino, 
suggesting that prdm1a also may be activating programs that are required for their 
expression and subsequently for EMT and migration. This is a very interesting finding 
because prdm1a is expressed early in the NPB and, by in situ hybridization, its 
expression is turned off prior to neural crest migration from the neural tube (Hernandez-
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Lagunas et al., 2005). This suggests that some of these programs required for EMT and 
migration are regulated at the NPB during this early stage of neural crest specification 
and are initiated much earlier in development than previously thought.  
 The growing strength of zebrafish as a genetic and molecular model and the 
increased accessibility of deep sequencing technologies make unbiased approaches such 
as ChIP-seq and RNA-seq an excellent tool for identifying novel gene regulatory 
interactions and understanding cell fate specification. Using these tools, I have shown the 
importance of the Prdm1a transcription factor in regulating several aspects of neural crest 
specification and development as well as its interaction with other cell types and tissues 
such as Rohon-Beard neurons and sensory placodes. These data have also provided 
several interesting new genes and networks that require further study to understand their 
role in neural crest development and will continue to contribute to the growing gene 














CDON REGULATES NEURAL CREST MIGRATION DOWNSTREAM  
OF PRDM1A 
Abstract 
Embryonic neural crest cells are first specified at the neural plate and then 
undergo an epithelial-to-mesenchymal transition (EMT) and migrate away from the 
neural tube to populate various developing tissues and differentiate into their final fate. 
Previous work in our lab has demonstrated the requirement of the transcription factor 
Prdm1a in specifying neural crest cells during early zebrafish embryogenesis. Here, I 
demonstrate a separate role for Prdm1a in regulating neural crest EMT and migration 
following specification. I hypothesize that Prdm1a regulates genes that are required for 
neural crest cell migration and have determined a novel role of one of these downstream 
targets, cdon, in Prdm1a-mediated neural crest migration. cdon is expressed early in 
developing premigratory neural crest cells (NCCs) and is required cell-autonomously for 
directed migration of the NCCs within the trunk. Loss of cdon results in aberrant 
migration of trunk NCCs and failure in formation of ventral trunk derivatives including 
melanocytes. These studies demonstrate a role for Prdm1a as a regulator of neural crest 
migration genes, including the novel neural crest migratory regulator cdon, in addition to 
its previously recognized role in neural crest specification. 
Introduction 
prdm1a mutant embryos have a defect in neural crest specification, with 
decreased numbers of NCCs available to migrate at later stages. However, even when 
NCCs are rescued in prdm1a mutants by re-introduction of the neural crest specifier, 
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foxd3, the specified NCCs are still unable to migrate from the dorsal neural tube (Figure 
5.1). This suggests that Prdm1a has a second role in regulating genes required for neural 
crest EMT and/or migration, separate from and subsequent to its role as a neural crest 
specifier. To determine what some of these neural crest migratory targets might be, I 
analyzed the RNA-seq dataset from 11 hpf and previously published microarray from 25 
hpf (Olesnicky et al., 2010) comparing prdm1a deficient embryos to wildtype embryos 
specifically for genes that have a demonstrated role in cell adhesion, motility, and 
migration. One of the genes I identified for further study was Cell-adhesion molecule-
related/down-regulated by Oncogenes or cdon.  
cdon is a member of the neural cell adhesion molecule (N-CAM) family. It 
contains an extracellular domain comprising of 5 Ig-like domains and 3 fibronectin type 
 
Figure 5.1. prdm1a mutant NCCs rescued by foxd3 expression do not migrate. 
ISH of NCC markers crestin and sox10 in the trunk of 24 hpf embryos. In wildtype 
embryos, NCCs migrate in streams ventrally from the dorsal neural tube, while in 
prdm1a mutants, there is a decreased numbers of NCCs and the NCCs that remain do 
not migrate (black arrows). When specification of NCCs is rescued by overexpression 
of foxd3 mRNA, NCC number is rescued, however the resuced NCCs do not migrate 
ventrally (white arrows) suggesting a subsequent role for prdm1a in NCC migration. 
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III-like repeats. In mouse, it has been identified as a Shh receptor, possibly acting as a co-
receptor with Patched1 (Tenzen et al., 2006; Zhang et al., 2006; Allen et al., 2011; Izzi et 
al., 2011). In myoblast and neuronal differentiation, it binds N-cadherin and induces 
p38/MAPK signaling to direct cell differentiation and apoptosis (Lu and Krauss, 2010). 
In chicken embryos, Cdon and associated receptor BOC (Brother of Cdon) have been 
found to localize to long filopodial protrusions in Shh-responding cells and act as long-
distance receptors for cell signaling response (Sanders et al., 2013). Additionally, Cdon is 
expressed in the developing NPB and premigratory NCCs in E7.5-8.5 mice (Mulieri et 
al., 2000). Cdon-/- mice display microform holoprosencephaly which is thought to be a 
result of deficient Shh signaling (Cole and Krauss, 2003), although it is not known if they 
are deficient in NCC development. Together, these studies suggest that cdon may have a 
conserved role in NCC development and specifically in NCC migration. 
Here, I demonstrate the role of cdon in zebrafish NCC migration. cdon is 
expressed in developing pre-migratory NCCs at multiple developmental stages and is 
regulated by prdm1a. Loss of cdon leads to a decrease in ventral migration of the trunk 
NCCs, loss of ventral melanocytes, and aberrant migration of NCCs in the dorsal neural 
tube. cdon functions cell-autonomously to regulate directed NCC migration through 
proper localization of N-cadherin to the cell surface possibly at sites of cell-cell contact in 
pre-migratory NCCs. Together, these data suggest a novel role for cdon in prdm1a-






Materials and methods 
In situ hybridization 
Whole-mount RNA in situ hybridization (ISH) was performed as previously 
described (Thisse and Thisse, 1998). Probe sequences were cloned from wildtype 
zebrafish cDNA into TOPO plasmids using the following primer sets: cdon. Additional 
probes for foxd3 and sox10 are previously published. 
Morpholino injections 
Embryos were injected at the 1-2 cell stage with morpholino designed to the ATG 
start codon of cdon (5’-ATC TCA GGC CAC CGT CCT CCA TGA C -3’) at doses 
ranging 1.5 to 3 ng. 
Live-imaging of transgenic embryos 
sox10:GFP embryos were injected with cdon morpholino as above and allowed to 
develop to 19-20 hpf. Embryos were imbedded in 1% agar with tricaine and imaged by 
spinning-disk confocal microscopy.  
Transplantations 
Approximately 25-50 cells were transplanted from the presumptive neural plate 
border of wildtype or morpholino injected sox10:GFP embryos at blastomere stage to the 
presumptive neural plate border of sox10:RFP embryos in penicillin-streptomycin treated 
embryo media. Embryos were allowed to develop then live-imaged at 30 hpf by 
fluorescent compound microscopy. Morpholino injected embryos were co-injected with 






Wildtype and cdon MO injected embryos were fixed in 4% PFA, embedded and 
cryo-sectioned at 24 hpf. Immunofluorescent staining on 12 μm sections over the yolk 
extension was performed using MNCD2 antibody (DSHB) and GFP antibody 
(Invitrogen) and imaged via spinning-disk confocal. 
Results 
cdon is expressed in developing NCCs 
cdon is a potential cell-adhesion regulator and signaling receptor that is expressed 
in the mouse NPB and is downstream of Prdm1a in zebrafish (Mulieri et al., 2000; 
Olesnicky et al., 2010). To determine if cdon may be involved in neural crest 
development, I performed in situ hybridization (ISH) to analyze the expression pattern of 
cdon in zebrafish embryos. During neural crest specification stages, cdon is expressed 
specifically in the NPB (Figure 5.2). During NCC migration, cdon is expressed in the 
dorsal neural tube as well as diffusely in the developing muscle and head. To show if 
cdon is expressed in NCCs during migration stages, I performed double fluorescent ISH 
with probes for cdon and a NCC marker, crestin. At 24 hpf, cdon is expressed only in the 
pre-migratory NCCs within the dorsal neural tube of the trunk (Figure 5.2). NCCs within 
the migratory pathways do not express cdon, suggesting that its expression may be 
downregulated prior to emigration of the NCCs from the neural tube. Due to the 
widespread expression of cdon in the head, it is unclear if this expression pattern applies 
to cranial NCCs as well. 
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cdon is regulated by prdm1a 
To confirm that cdon is regulated by prdm1a, I performed in situ hybridization for 
cdon in prdm1a morphant embryos at several stages of neural crest development. At 2 
somites, cdon expression at the NPB appears unchanged in prdm1a morphants, 
 
Figure 5.2. cdon is expressed in the NPB and premigratory NCCs of the trunk. 
ISH of 2 somite and 24 hpf stage wildtype embryos shows cdon expressed in the NPB 
and dorsal neural tube (arrows). Double fluorescent ISH was performed on 24 hpf 
wildtype embryos for crestin and cdon. cdon is expressed in premigratory NCCs in the 
trunk (A) and widely expressed in cranial NCCs (B). 
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suggesting that prdm1a is not required for initiation of cdon expression (Figure 5.3). By 
24 hpf, when NCCs are migrating throughout the trunk, cdon expression is refined to the 
dorsal neural tube in premigratory NCCs. In prdm1a morphants, cdon expression within 
the premigratory NCCs appears increased, supporting the results of the previously 
published microarray (Olesnicky et al., 2010). This suggests that prdm1a negatively 
regulates cdon in an indirect manner within premigratory NCCs.  
cdon is required for neural crest migration 
After determining that cdon is expressed at the right time and place to be involved 
in neural crest specification and/or migration, and is regulated by prdm1a, I wanted to 
determine if cdon is required for neural crest development. I designed a morpholino 
targeting the start site of cdon to knockdown its expression. I injected different doses of 
morpholino to determine a dose with little to no non-specific effects on embryogenesis. 
Upon knockdown of cdon, I performed ISH for markers of neural crest specification, 
foxd3 and sox10 at 2 and 4 somites, respectively, and sox10 and crestin to mark NCCs at 
migratory stages. In cdon morphant embryos, foxd3 and sox10 expression at 2-4 somites 
 
Figure 5.3. prdm1a regulates cdon expression in the dorsal neural tube. 
ISH of cdon in trunk of wildtype and prdm1a morphant embryos at 24 hpf. cdon 
expression is maintained primarily in the dorsal neural tube and is upregulated in 
prdm1a morphants, suggesting that prdm1a negatively regulates cdon. 
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appears unchanged compared to wildtype controls (Figure 5.4). However, in later stage 
embryos, it appears that, while the number of NCCs remains normal, migration of the 
NCCs is impaired primarily in the trunk (Figure 5.5). NCCs appear to exit the dorsal 
neural tube and move ventrally a short distance, but do not migrate as far ventrally as 
wildtype NCCs. Addtionally, ectopic NCCs are observed along the dorsal midline of 
cdon morphant embryos. By 48 hpf, neural crest derivative melanocytes do not appear to 
have migrated to populate the ventral regions of cdon morphant embryos as they do in 
wildtype. Interestingly, when craniofacial cartilages are stained using alcian blue at 5 dpf,  
 
Figure 5.4. cdon is dispensable for neural crest specification. 
ISH for neural crest specification markers foxd3 and sox10 shows no change in 
expression between wildtype and cdon morphants, demonstrating that cdon does not 






Figure 5.5. cdon is required for trunk neural crest migration. 
ISH for neural crest markers sox10 at 18 somites (A) and crestin at 24 hpf (B) in 
wildtype and cdon morphant embryos. In wildtype, NCCs migrate in streams ventrally 
from the neural tube, while cdon morphant NCCs do not migrate ventrally. Imaging of 
melanocytes at 48 hpf (C) displays loss of ventral melanocytes in cdon morphants 
compared to wildtype, suggesting NCCs do not reach ventral positions. ISH of neural 
crest marker crestin at 16 somites, dorsal view, anterior to the top (D). In cdon 
morphants, NCCs can be seen along the dorsal midline, suggesting that NCCs are not 
migrating in the proper direction. 
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there appears to be no major differences in patterning and formation of the cartilage 
between cdon MO and wildtype embryos (Figure 5.6). Together, these data suggest that 
cdon is dispensable for neural crest specification at the NPB, however it is required for 
migration of NCCs specifically within the trunk.  
While static ISH images allowed me to visualize general changes in NCC 
migration, I wanted to observe the behavior of NCCs in the absence of cdon. I utilized 
transgenic sox10:GFP embryos to live-image migratory NCCs under wildtype and 
morphant conditions and performed time-lapse imaging from 19-24 hpf when trunk 
NCCs are migrating (Figure 5.7). While wildtype NCCs migrate in a stereotypic manner 
by creating stable protrusions ventrally and migrating in narrow pathways along the 
somite, cdon morphant NCCs exhibit abnormal morphology and appear to be highly 
 
Figure 5.6. cdon is not required for cranial neural crest migration and 
development. 
Alcian blue staining of cartilage at 5 dpf shows normal formation of cartilage in 
wildtype and cdon morphant embryos. 
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motile, extending short, rapid protrusions in multiple directions (Figure 5.7). Several 
NCCs appear to exit the dorsal neural tube but then stall in the migratory pathway and do 
not migrate further ventrally, supporting what was observed in the static ISH images. 
 
Figure 5.7. Live imaging of cdon morphants reveals defects in migrating NCC 
morphology and directed cell migration. 
Live imaging of wildtype (A) and cdon morphant (B) sox10:GFP embryos from 19-24 
hpf shows failure of directed NCC migration in cdon morphants. High resolution 
image of migrating NCCs (apx. 22 hpf) in wildtype and cdon morphants (C) displays 
abnormal cellular morphology and protrusions in cdon morphant embryos. 
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This suggests that cdon is required for directed cell migration of trunk NCCs possibly by 
regulating cell motility and/or adhesion. 
cdon is required cell-autonomously 
To determine if cdon is required cell-autonomously for NCC migration rather 
than within the migratory environment, I performed transplant experiments by 
transplanting cdon morphant NCCs into a wildtype background. I injected cdon 
morpholino into sox10:GFP embryos and transplanted cells at the blastomere stage from 
the presumptive neural crest of donor embryos into the same region of uninjected 
sox10:RFP host embryos so that I would be able to visualize both donor and host NCCs 
at migratory stages. I then imaged embryos at 30 hpf, by which time the majority of 
wildtype (RFP+) host NCCs are migrating (Figure 5.8). cdon MO donor NCCs (GFP+) 
however did not migrate from the dorsal neural tube within the trunk. Cranial NCCs on 
the other hand seem to be able to migrate normally, supporting previous data suggesting 
the role of cdon in neural crest migration is specific to trunk NCCs. Control experiments 
transplanting wildtype NCCs into either morphant or wildtype hosts resulted in normal 
migration of donor cells along the host migratory pathway, suggesting that cdon is not 
required within the migratory environment but is a cell-autonomous regulator of trunk 
NCC migration. 
cdon regulated N-cadherin localization during NCC migration 
 To determine the mechanism by which cdon regulates NCC migration, I analyzed 
the expression and subcellular localization of the adhesion protein N-cadherin during 
NCC migration. In various cell types, Cdon has been shown to bind N-cadherin (Lu and 
Krauss, 2010). As cadherin expression at the cell surface and specifically regulation of N-
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cadherin is crucial for proper migration of NCCs, I used antibody staining to determine 
the regulation of N-cadherin expression and localization in cdon morphant NCCs. I 
injected cdon morpholino into sox10:GFP transgenic embryos, fixed and cryo-sectioned 
(12 μm sections) at 24 hpf, and performed sectional immunofluorescent antibody staining 
using a mouse N-cadherin antibody (MNCD2, DSHB) and GFP antibody (Invitrogen) to 
label the NCCs. In wildtype embryos, N-cadherin localizes primarily to the cell surface 
of premigratory NCCs, with expression diminishing in migrating NCCs (Figure 5.9). In 
cdon morphants, however, N-cadherin expression is seen diffusely throughout the 
cytoplasm of the premigratory NCCs and no longer is localized to the membrane where it 
may act as a cell adhesion molecule. This suggests that Cdon regulates N-cadherin 
localization in trunk NCCs, possibly through binding N-cadherin and localizing it to the 
 
Figure 5.8. cdon is required cell-autonomously for NCC migration. 
Presumptive NCCs from cdon morphant sox10:GFP embryos were transplanted into 
the presumptive neural plate border of 4 hpf wildtype sox10:RFP host embryos and 
imaged at 30 hpf. Donor cells from cdon morphants were unable to migrate in 
wildtype host background, suggesting that cdon is required cell autonomously for 
NCC migration. WT into WT and WT into cdon MO transplants were performed as 
controls and transplanted donor NCCs were seen to migrate normally. 
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cell membrane, and that misregulation of N-cadherin localization may result in abnormal 
or inhibited NCC migration.  
Discussion 
 Prdm1a is required for specification of NCCs at the NPB. It also appears to have a 
secondary role in neural crest migration. As a transcription factor, it has been shown to 
regulate many genes at different stages of development that play distinct roles in neural 
crest development; one of these genes is cdon. Here, I have demonstrated a novel role for 
cdon in neural crest migration. While it is expressed in the NPB, cdon does not play a 
role in neural crest specification. It is, however, required for migration of trunk NCCs 
 
Figure 5.9. N-cadherin is mislocalized in cdon morphant NCCs. 
Confocal imaging of cross-sectional immunofluorescent staining (12 μm sections, 1 
μm optical sections) of the neural tube show N-cadherin localized to the cell surface 
of sox10:GFP-positive NCCs in wildtype transgenic embryos at 24 hpf (DAPI in blue, 
N-cadherin in red, sox10:GFP in green). N-cadherin in cdon morphant NCCs localizes 
to cytoplasm (see asterisks denoting NCCs). 
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ventrally from the dorsal neural tube. cdon cell-autonomously regulates NCC motility 
and directed cell migration within embryonic trunk NCCs. cdon appears to regulate the 
subcellular localization of N-cadherin within premigratory NCCs and the misregulation 
of N-cadherin localization may contribute to the migratory defects observed in cdon 
morphant NCCs. 
 Expression of cdon is initiated in the NPB prior to the 2-somite stage, during the 
time of neural crest specification. While it does not appear to play a role in specification, 
loss of cdon during development impairs neural crest migration at later stages. This 
supports the idea that genes that are activated early in neural crest development, such as 
prdm1a, play a crucial role in later stages and that the programs required for neural crest 
EMT and migration are actually initiated very early in the life of NCCs. Even though 
migration of NCCs occurs at a later developmental stage, genes that are required for 
specification and migration are expressed concurrently. This also suggests that a long 
priming time for neural crest migration may be necessary for proper migration to occur. 
Interestingly, prdm1a is a negative regulator of cdon in an indirect manner; knockdown 
of prdm1a does not affect cdon expression until long after prdm1a is downregulated in 
NCCs. This suggests that prdm1a regulates pathways that have long-reaching effects far 
downstream in neural crest development. The defects in cdon morphants are not seen 
until the 18-somite stage when NCCs are beginning to emigrate from the dorsal neural 
tube in the trunk. By in situ hybridization for neural crest markers, it appears that the 
NCCs are able to delaminate and begin migrating ventrally; however, they appear to stall 
just ventral to the neural tube, while wildtype NCCs continue migrating in streams to far 
ventral sites of differentiation. Indeed, when I analyze the appearance of neural crest 
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derivatives such as melanocytes, the ventral-most population of NCCs never arrives to its 
final differentiation site. Interestingly, this defect is restricted to trunk NCCs, suggesting 
a separate, cdon-independent mechanism for cranial NCC migration. This is not 
surprising as the migratory environment for cranial and trunk NCCs is likely very 
different and many mechanisms of directed cell migration appear to diverge in these two 
populations. 
 The role of cdon in NCC migration is most apparent when analyzing cell 
behaviors in live zebrafish embryos. Here, I see an increase in cell motility as evidenced 
by increased cell protrusions in cdon morphants. I also observe decreased directed cell 
migration which could be due to defects in cell polarity. Together, this suggests that cdon 
may be playing multiple roles in cell migration, both by regulating cell motility and by 
regulating cell polarity which is necessary for directed migration. There are several 
potential cellular mechanisms that are regulated by cdon. In myogenesis, cdon has been 
shown to bind and ligate N-cadherin, which contributes to muscle cell differentiation 
(Goichberg and Geiger, 1998; Gavard et al., 2004; Lu and Krauss, 2010). As regulation 
of adherens junctions and cell-cell contact is essential for proper control of NCC EMT 
and migration, it is possible that cdon is involved in the regulation of N-cadherin or other 
Cadherin proteins. It is apparent in cdon morphant NCCs that N-cadherin is mislocalized 
during migration of trunk NCCs. In wildtype embryos, N-cadherin is localized to the cell 
membrane of NCCs while in cells lacking cdon, N-cadherin protein is observed diffusely 
throughout the cytosol. As the Cdon protein can bind N-cadherin directly, it is 
conceivable that Cdon is required to regulate the localization of N-cadherin and possibly 
other cadherin proteins during neural crest migration perhaps by trafficking of cadherins 
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to the cell membrane prior to migration. Previous studies have suggested that N-cadherin 
and Cdon bind in cis at the plasma membrane of cells (Kang et al., 2003; Lu and Krauss, 
2010), supporting the model that Cdon and N-cadherin may bind at the membrane of 
premigratory NCCs. It is also possible that Cdon is required to bind N-cadherin at the 
surface of neighboring NCCs to mediate cell-cell adhesion or contact-dependent 
signaling between premigratory NCCs within the dorsal neural tube. The misregulation of 
N-cadherin localization could contribute to premature delamination of the NCCs within 
the dorsal neural tube, demonstrated by the increased motility and aberrant migration of 
NCCs dorsally and the ectopic movement of NCCs across the midline of the embryo that 
is observed in cdon morphant embryos. As the NCCs lose their cell-cell contacts and 
migrate within or dorsal to the neural tube, it is possible that they are no longer able to 
properly polarize or communicate with other NCCs and cells of the migratory 
environment, preventing the NCCs from migrating ventrally to their final destinations. 
Additionally, the mislocalization of N-cadherin away from the membrane could cause a 
loss of downstream N-cadherin mediated signaling such as p38/MAPK. The involvement 
of such signals during neural crest migration is still poorly understood.  
Another role of cdon is downstream of Sonic hedgehog signaling (Shh). Cdon 
protein binds directly to the Shh ligand, possibly acting as a co-receptor for Patched1 
(Tenzen et al., 2006; Yao et al., 2006). In mesenchymal cells, Cdon localizes to 
microdomains within long, filpodial protrusions which are thought to be important in the 
transport of Shh signaling components for long-range signaling events (Sanders et al., 
2013). While the role of Shh signaling in neural crest migration is not well established, 
there is some evidence that Shh may play a role in the migration of NCCs and some of 
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their derivatives including cells of the dorsal root ganglia (Ungos et al., 2003). 
Furthermore, there is evidence that Shh may play a role in EMT of some cell types and 
provide positional cues in cranial and enteric NCCs (Ramalho-Santos et al., 2000; Mo et 
al., 2001; Li et al., 2006; Tobin et al., 2008; Yoo et al., 2008). It is possible that cdon is 
required to receive and interpret Shh signals which are required for proper EMT and 
migration of trunk NCCs, but this interaction remains unclear. 
 Cdon is a conserved cell-surface protein in mammals. Previous work has 
demonstrated cdon (or cdo) expression in the developing mouse neural folds, NPB, and 
premigratory NCCs (Mulieri et al., 2000). The cdon-/- mouse exhibits microform 
holoprosencephaly consisting of defects in some but not all cranial neural crest 
derivatives (Cole and Krauss, 2003), however trunk neural crest migration and 
derivatives were not analyzed. It is possible that cdon has similar roles in mouse neural 
crest migration as it does in zebrafish. Additionally, there could be redundant proteins 
such as the related protein BOC contributing to neural crest migration in mouse that may 
ameliorate the cdon mutant phenotype. In human cells, Cdon has been identified as a pro-
apoptotic tumor suppressor which is downregulated in colon, kidney, lung, and breast 
cancer tumor cells of human patients (Delloye-Bourgeois et al., 2013). Interestingly, in 
prostate cancer, Cdon was found to be upregulated and knockdown of Cdon impaired 
tumor cell invasion and survival (Hayashi et al., 2011). Mutations in Cdon are also 
associated with human holoprosencephaly, supporting its identified role in mouse 
craniofacial development (Bae et al., 2011). This suggests that the role of Cdon could be 
conserved across both fish and mammals and that Cdon may be an important regulator of 





 This body of work demonstrates the importance of the transcription factor Prdm1a 
in neural crest and embryonic development. Previously, it was understood that Prdm1a is 
required for neural crest specification; however it was unclear how Prdm1a regulates 
neural crest specification and what other roles it is playing in development. Determining 
the downstream targets of Prdm1a has shown how integral it is to neural crest formation 
and has established its role as a master regulator of several gene regulatory networks that 
allow cells of the embryo to make the proper cell fate choices. Understanding the 
mechanisms of gene regulation in the neural crest can be applied to help us understand 
how many cell types are specified and how tissues and cells interact on a molecular level 
to contribute to global embryonic development. 
 These studies have allowed me to place Prdm1a within the current known gene 
regulatory network required for neural crest formation. prdm1a expression is induced at 
the NPB early in development by BMP and possibly other signaling pathways. Wnt and 
Notch signals negatively regulate prdm1a, maintaining its expression at the proper levels, 
while positively regulating neural crest specifiers. The Prdm1a transcription factor 
directly activates genes required for neural crest specification, while directly inhibiting 
other genes allowing NCCs to develop (Figure 6.1). I have identified several genes 
directly targeted by Prdm1a as well as many other genes that are regulated downstream of 
Prdm1a transcriptional activity. These genes are involved in a wide array of programs 
including sensory placodal development, EMT, cell polarity, and migration. Several 
novel genes were identified that are regulated by prdm1a at the NPB, including the cell 
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adhesion gene cdon, for which I have demonstrated a novel role in regulating N-cadherin 
localization and directed migration of NCCs. These genes provide interesting candidates 
for further study of the neural crest gene regulatory network, which will in turn contribute 
to our understanding of how tissues and cells interact during development, how cells 
migrate during embryogenesis and metastasis, and could identify new candidates that 




Figure 6.1. Model of Prdm1a regulation of target genes in the NPB, developing 
NCCs, and neighboring tissues. 
Prdm1a is induced at the NPB during mid-gastrulation in zebrafish. It directly targets 
neural crest specifier genes tfap2a and foxd3 for activation, which in turn induce the 
neural crest developmental program. Concurrently, Prdm1a regulates genes required 
for proper EMT and migration of NCCs including adhesion, motility, and polarity 
genes, and potential migratory regulators such as cdon, potentially via indirect and 
direct mechanisms. Prdm1a also regulates neighboring tissue development, including 
repression of genes that are required for neural development, such as olig4, and 
potentially repression of non-neural ectoderm (NNE) genes to allow the NPB and 
NCCs to form within a precise domain. Prdm1a also positively regulates expression of 
placode specification genes including six1b an eya1/2. Solid arrows demonstrate direct 
targeting, dashed arrows suggest indirect interactions. 
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Wnt and Notch signaling regulate Prdm1a expression and neural crest induction 
 Some of the earliest events in neural crest development are regulated by signaling 
factors. The complex interaction of signaling pathways and how they cooperate to induce 
the NPB and neural crest has been widely studied. Wnt and Notch signals are both known 
to be required for neural crest specification; when these signals are abrogated, NCCs are 
not properly induced or formed. Neural crest specifier genes are some of the main targets 
of Wnt and Notch signaling pathways. prdm1a is also a target of these pathways, 
however it is regulated in a different manner from the other specifier genes. While most 
known neural crest specifiers are positively regulated by Wnt and Notch, prdm1a is 
inhibited by both of these signals possibly through direct or indirect mechanisms. This 
suggests that while prdm1a is required for neural crest specification, its expression must 
be negatively regulated for proper neural crest formation. It is possible that prdm1a is 
also involved in inhibition of neural crest gene expression to maintain the proper size of 
domain for neural crest formation, and thus its expression must also be properly 
regulated.  
While these signaling pathways appear to negatively regulate prdm1a expression, 
it is still unclear what signals and genes are required to induce prdm1a at the early NPB. 
While it is known that BMP contributes to prdm1a initiation at the NPB, it is possible 
that other signals such as FGF which is involved in early induction of the NPB also 
regulates prdm1a expression. It is also possible that one or more of the NPB specifiers 
such as msx, dlx, and pax genes turn on prdm1a expression prior to neural crest 
specification. Identifying the factors that positively and negatively regulate prdm1a is 
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important to understanding the role of prdm1a in neural crest specification and can 
provide clues for further gene pathways and cascades that it regulates. 
Prdm1a directly regulates neural crest specification 
After prdm1a is induced and properly regulated at the NPB, it then becomes a 
transcriptional activator of foxd3 and tfap2a and potentially other genes as well to specify 
NCCs. It is also required as a transcriptional repressor; if this role is inhibited, migratory 
NCCs are not formed. There are several potential genes that Prdm1a inhibits, including 
inhibitors of NCC specification, EMT, and migration. This suggests a novel mechanism 
of Prdm1a transcriptional regulation of neural crest target genes whereby Prdm1a 
functions as both a transcriptional activator and repressor. It is unclear how Prdm1a 
regulates various target genes differently across different cells types and developmental 
stages. As the Prdm1a protein contains several potential protein-protein interaction 
domains, I speculate that different transcriptional co-factor binding partners may help 
facilitate the alteration in Prdm1a transcriptional regulation on different target promoters 
and enhancers. Further study to identify what proteins bind Prdm1a during different 
stages of neural crest development and at different target sites will contribute greatly to 
our understanding of how NCCs are specified and how transcription factors like Prdm1a 
and others regulate their targets in multiple cell types. 
While direct regulation of foxd3 and tfap2a explain the importance of Prdm1a in 
neural crest specification, it is likely that Prdm1a regulates many other genes that play 
significant roles in NCCs. Using deep sequencing techniques, I have identified and 
confirmed the regulation of several genes expressed in or near the NPB by prdm1a. Some 
of these genes appear to be direct targets while others are likely indirect. While some of 
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these genes like kctd15a have a demonstrated role in neural crest development, many of 
these genes are interesting novel candidates that will need further study to identify their 
role downstream of prdm1a in neural crest and other cell fates, such as cells of the 
placode, neural plate, and surrounding non-neural ectoderm. 
The role of Prdm1a in regulating neural crest migration 
 prdm1a is expressed early in the NPB and its expression is no longer detectable 
by the end of neural crest specification, suggesting that it is downregulated well prior to 
neural crest migration. Interestingly, there is evidence that prdm1a is necessary for neural 
crest migration discretely from its role in specification. Even when neural crest 
specification is rescued in prdm1a mutants, the rescued NCCs are unable to migrate. This 
suggests that Prdm1a is not only required to activate neural crest specification but genes 
required for neural crest migration and possibly EMT as well. Several genes with known 
or potential roles in cell adhesion, motility, and migration were identified by RNA-seq 
and microarray as being regulated by prdm1a. These include cadherins and integrins 
expressed in NCCs, Rac and Rho/ROCK genes that are involved in NCC polarity and 
directed migration, and matrix metalloproteinases required for cell invasion and 
migration. It is of note that these programs of genes were found to be regulated by 
prdm1a at the 2-somite stage, long before NCCs will begin to migrate from the neural 
tube. This suggests that neural crest and NPB specifiers such as prdm1a are able to 
initiate genes required for these later processes much earlier in development than 
previously known. It is possible that additional neural crest specifiers are also initiating 
and contributing to programs required for EMT and migration very soon after neural crest 
specification in the NPB. 
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 One of the genes initiated in the NPB that functions later in neural crest migration 
is the cell adhesion gene, cdon. While cdon is expressed in the NPB and regulated by 
prdm1a, it is dispensable for neural crest specification. cdon is cell-autonomously 
required for proper migration of NCCs and appears to regulate cell motility and directed 
cell migration. It appears to regulate the subcellular localization of the adhesion genes N-
cadherin within premigratory and migratory NCCs. Its regulation of other members of the 
cadherin family as well as its potential role downstream of long-range Shh signaling as a 
receptor protein on the membrane of cell protrusions have yet to be investigated. As both 
cell motility and directed migration are altered in cdon morphant NCCs, it is probable 
that cdon plays multiple roles in migratory NCCs. Interestingly, there is some evidence 
that cdon is involved in cancer cell survival and invasion in human patients. As cdon is a 
highly conserved gene in fish and mammals, it is a very interesting candidate for further 
study in understanding NCCs as well as tumor cell survival and metastasis. 
The importance of gene regulatory networks in understanding development 
 In the previous pages, I have developed a model of Prdm1a gene regulation and 
the network of pathways that it helps to regulate and integrate. Gene regulatory networks 
are instrumental in our understanding of genetic programs in embryonic development as 
well as in adult cells during normal tissue homeostasis and in disease states such as 
cancer. They are able to give us a wider view of how particular genes and pathways 
interact with one another within cells and across tissues. Analyzing gene regulatory 
networks can also show us similarities between seemingly diverse cell functions. For 
instance, understanding how NCCs undergo EMT and migration has demonstrated 
multiple similarities with how cancer cells delaminate from the primary tumor and 
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metastasize to colonize distant tissues. It becomes apparent that many genes and 
signaling pathways are common between these two disparate conditions and that studying 
NCCs can yield clues for understanding cancer progression and metastatic disease. With 
the accessibility of high throughput sequencing, building large gene regulatory networks 
has become faster and more efficient, allowing researchers to integrate their gene or 
pathway of interest into a larger body of scientific knowledge.  
 Cell fate choices are not made by single genes but by networks of signaling 
molecules and transcription factors. Understanding how one gene, such as prdm1a, fits 
into the known gene regulatory network and how it regulates novel players in this 
network can explain a lot about its function within specific cells, tissues, and within the 
whole embryo. In addition, identifying novel gene functions contributes to our 
knowledge of development and provides new candidates for further study and potential 
therapeutic targets or genetic markers for human disease. Unraveling these complex 
pathways and investigating how they interact will help us better understand cell fate and 
behavior choices within the context of development and disease. 
While this thesis has provided many new insights into the role of prdm1a in 
neural crest development, there are still many exciting new questions to explore. One of 
the most interesting questions is how a transcription factor like Prdm1a or any other 
similar protein is able to target different genes for transcriptional activation and/or 
repression in different cell types or in the same cell at different developmental periods. 
While the role of and requirement for various transcription factors has been well studied 
in many developmental processes including neural crest development, the role of co-
factor binding and partner choice is less understood, but would appear to provide 
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valuable understanding of cell fate choices. How transcription factors eschew one binding 
partner for another in response to external cues and how quickly these processes occur to 
respond to rapidly changing developmental stages and environments is of great interest. 
Another interesting question that remains is how developmental genes and pathways that 
are initiated early in development continue to play an important role at later stages as 
well. While it is important to understand direct relationships between proteins and genes 
within cells and at specific developmental timepoints, it is also useful to understand 
indirect relationships such as the relationship between prdm1a and cdon. It remains 
unclear how cells and tissues can relay and interpret signals across long developmental 
times but it is clear that these signals and pathways are important. Specifically in neural 
crest development, how early NPB and neural crest specifiers either directly or indirectly 
program NCCs for subsequent EMT and migration is a very interesting topic with much 
to explore. Lastly, I am very interested in how migratory cells such as NCCs both 
influence and respond to the environments through which they migrate. Are NCCs a 
homogenous population prior to emigrating from the neural tube and is their final fate 
choice primarily reliant on external cues from the migratory environment? How do 
migrating cells know when they have reached their final differentiation place and must 
they undergo a reverse EMT or mesenchymal-to-epithelial transformation to complete 
differentiation and integration into their final tissue? As migrating NCCs have much in 
common with metastatic tumor cells, understanding these types of questions may yield 
much information about how cancer cells interact with their microenvironment as well. 
Investigating these and further questions about NCCs and development of other cell types 
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on a cellular and molecular level will give us an even greater understanding of how 
tissues and organisms are successfully formed and how we might respond when they fail. 
In conclusion, understanding how transcription factors like Prdm1a interpret 
signals and regulate multiple targets throughout different cell types and developmental 
stages is crucial to understanding the complex processes of cell fate specification and 
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COMPLETE LIST OF PRDM1A CHIP-SEQ TARGETS IDENTIFIED 
 
Gene Name Ensembl ID Location of peak
Distance to 
Start Site
chic2 ENSDARG00000022690 chr1:13293903-13294043 3060
LOC100538278 ENSDARG00000086960 chr1:2600178-2600302 -41021
NA ENSDARG00000037253 chr1:26652834-26652953 107511
ndst3 ENSDARG00000041776 chr1:18982016-18982162 72515
sorcs3 ENSDARG00000075865 chr1:48828657-48828865 222021
wu:fc18f06 ENSDARG00000087467 chr1:3630095-3630232 -150573
fbn2 ENSDARG00000079729 chr10:16735155-16735567 -79527
fbn2 ENSDARG00000079729 chr10:16736623-16737050 -78059
fbn2 ENSDARG00000079729 chr10:16745233-16746083 -69449
fbn2 ENSDARG00000079729 chr10:16751856-16752639 -62826
fbn2 ENSDARG00000079729 chr10:16774578-16775050 -40104
fbn2 ENSDARG00000079729 chr10:16788373-16788920 -26309
fbn2 ENSDARG00000079729 chr10:16793525-16793887 -21157
fbn2 ENSDARG00000079729 chr10:16809213-16809481 -5469
LOC565449 ENSDARG00000078006 chr10:39369747-39370016 13285
LOC798222 ENSDARG00000021065 chr10:46255161-46255296 30924
lpar1 ENSDARG00000044213 chr10:12016259-12016556 119003
lpar1 ENSDARG00000044213 chr10:12016869-12017136 118393
lpar1 ENSDARG00000044213 chr10:12023150-12023278 112112
lpar1 ENSDARG00000044213 chr10:12027715-12027908 107547
lpar1 ENSDARG00000044213 chr10:12029516-12029726 105746
lpar1 ENSDARG00000044213 chr10:12046562-12047032 88700
musk ENSDARG00000000102 chr10:13038456-13038652 104320
musk ENSDARG00000000102 chr10:13044789-13045007 97987
NA ENSDARG00000043167 chr10:13018738-13019206 107084
NA ENSDARG00000043167 chr10:13022589-13022827 110935
NA ENSDARG00000043167 chr10:13023180-13023394 111526
NA ENSDARG00000032975 chr10:15763678-15763851 26437
NA ENSDARG00000088483 chr10:23071871-23072063 -900
NA ENSDARG00000096498 chr10:46359815-46360036 4323
ogdhb ENSDARG00000073805 chr10:46226489-46226627 -16968
cpne5 ENSDARG00000070919 chr11:3005369-3005549 20237
dnah1 ENSDARG00000055736 chr11:35541076-35541197 -6999
fam19a4b ENSDARG00000062471 chr11:18066721-18068227 146795
fam19a4b ENSDARG00000062471 chr11:18068342-18068893 145174
NA ENSDARG00000070366 chr11:35982358-35983090 27325
wnt7aa ENSDARG00000044827 chr11:28282270-28282515 95027
zgc:55741 ENSDARG00000089293 chr11:15194660-15195081 7944




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
becn1 ENSDARG00000079128 chr12:15434921-15435325 -78957
becn1 ENSDARG00000079128 chr12:15439055-15439281 -74823
becn1 ENSDARG00000079128 chr12:15442487-15442693 -71391
becn1 ENSDARG00000079128 chr12:15445017-15445224 -68861
becn1 ENSDARG00000079128 chr12:15450038-15450243 -63840
becn1 ENSDARG00000079128 chr12:15451074-15451282 -62804
becn1 ENSDARG00000079128 chr12:15451469-15451675 -62409
becn1 ENSDARG00000079128 chr12:15452737-15453249 -61141
becn1 ENSDARG00000079128 chr12:15455905-15456501 -57973
becn1 ENSDARG00000079128 chr12:15463232-15463428 -50646
becn1 ENSDARG00000079128 chr12:15464352-15464754 -49526
becn1 ENSDARG00000079128 chr12:15473009-15473201 -40869
becn1 ENSDARG00000079128 chr12:15474233-15474440 -39645
becn1 ENSDARG00000079128 chr12:15476970-15477382 -36908
becn1 ENSDARG00000079128 chr12:15477973-15478203 -35905
becn1 ENSDARG00000079128 chr12:15479479-15479753 -34399
kcnj3 ENSDARG00000062672 chr12:16859405-16859679 296572
kcnj3 ENSDARG00000062672 chr12:16912647-16912838 243330
kcnj3 ENSDARG00000062672 chr12:16918663-16919105 237314
kcnj3 ENSDARG00000062672 chr12:16920012-16920246 235965
kcnj3 ENSDARG00000062672 chr12:16922952-16923172 233025
LOC563241 ENSDARG00000052772 chr12:3817108-3817453 29809
NA ENSDARG00000054528 chr12:6039515-6039692 16780
NA ENSDARG00000091768 chr12:32080224-32080592 3213
zgc:153920 ENSDARG00000070041 chr12:32198740-32198879 5915
c1d ENSDARG00000021112 chr13:4322037-4322334 -3126
LOC100333216 ENSDARG00000075119 chr13:7032721-7032937 32913
LOC100333216 ENSDARG00000075119 chr13:7033647-7034019 33839
mark3 ENSDARG00000019345 chr13:15447014-15447234 -87719
mark3 ENSDARG00000019345 chr13:15467499-15467695 -67234
mark3 ENSDARG00000019345 chr13:15468999-15469225 -65734
mark3 ENSDARG00000019345 chr13:15475528-15475849 -59205
mark3 ENSDARG00000019345 chr13:15491773-15491918 -42960
mark3 ENSDARG00000019345 chr13:15498837-15499046 -35896
NA ENSDARG00000085860 chr13:17074671-17074810 -299144
NA ENSDARG00000088518 chr13:48548421-48548824 26804
NA ENSDARG00000088229 chr13:48666418-48666558 21875
runx3 ENSDARG00000052826 chr13:45775414-45775828 121
fmr1 ENSDARG00000037433 chr14:21108250-21109274 -49494
fmr1 ENSDARG00000037433 chr14:21109481-21110182 -48263
im:7162965 ENSDARG00000018345 chr14:47177478-47177696 -72707
im:7162965 ENSDARG00000018345 chr14:47191510-47192210 -58675
im:7162965 ENSDARG00000018345 chr14:47198788-47198927 -51397
im:7162965 ENSDARG00000018345 chr14:47211008-47211190 -39177
LOC100005596 ENSDARG00000090986 chr14:8645717-8645929 28486




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
NA ENSDARG00000083139 chr14:47122977-47123203 73964
NA ENSDARG00000083139 chr14:47133021-47133143 84008
NA ENSDARG00000083139 chr14:47139797-47140289 90784
NA ENSDARG00000083139 chr14:47141924-47142406 92911
NA ENSDARG00000083139 chr14:47143156-47143370 94143
NA ENSDARG00000036829 chr14:17182939-17183235 139757
NA ENSDARG00000036829 chr14:17187462-17187801 135234
NA ENSDARG00000036829 chr14:17188134-17188689 134562
neurog1 ENSDARG00000056130 chr14:27713098-27713260 830
NA ENSDARG00000087470 chr15:46707991-46708149 -7908
NA ENSDARG00000063691 chr15:36871-37100 -2202
NA ENSDARG00000041874 chr15:7217428-7218766 32873
NA ENSDARG00000089864 chr15:10070155-10070290 -139641
NA ENSDARG00000057408 chr15:45149298-45150336 -267835
p4ha3 ENSDARG00000034058 chr15:13429160-13429975 -13266
zgc:193616 ENSDARG00000089241 chr15:9609079-9609991 26431
LOC100151419;
LOC100333218 ENSDARG00000090707 chr16:28154489-28155018 38903
LOC100151419;
LOC100333218 ENSDARG00000090707 chr16:28155113-28155252 38279
LOC100151419;
LOC100333218 ENSDARG00000090707 chr16:28155317-28155729 38075
NA ENSDARG00000035797 chr16:20247621-20247844 34422
NA ENSDARG00000035797 chr16:20272950-20273165 59751
NA ENSDARG00000035797 chr16:20290930-20291289 77731
NA ENSDARG00000035797 chr16:20295107-20295838 81908
NA ENSDARG00000035797 chr16:20297782-20298024 84583
NA ENSDARG00000035797 chr16:20298811-20299152 85612
NA ENSDARG00000035797 chr16:20299483-20300022 86284
NA ENSDARG00000094256 chr16:16606669-16607099 47732
NA ENSDARG00000094256 chr16:16607248-16607419 47153
NA ENSDARG00000094256 chr16:16612124-16612296 42277
NA ENSDARG00000094256 chr16:16622614-16623242 31787
NA ENSDARG00000094256 chr16:16635071-16635492 19330
NA ENSDARG00000094256 chr16:16636548-16637088 17853
NA ENSDARG00000094256 chr16:16640307-16640773 14094
zgc:110848;LOC
797125 ENSDARG00000088764 chr16:3230332-3230470 23981
LOC100331800 ENSDARG00000013134 chr17:40106371-40107756 -57571
LOC100331800 ENSDARG00000013134 chr17:40113941-40114249 -65141
LOC100537320 ENSDARG00000089514 chr17:3343222-3343356 32283
LOC100537383 ENSDARG00000090064 chr17:46610963-46611229 -59418
LOC100537383 ENSDARG00000090064 chr17:46623474-46623676 -46907
LOC100537383 ENSDARG00000090064 chr17:46633599-46633944 -36782
LOC100537383 ENSDARG00000090064 chr17:46639085-46639454 -31296




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
NA ENSDARG00000037656 chr17:47992817-47993793 21146
NA ENSDARG00000037656 chr17:48009731-48009953 38060
NA ENSDARG00000089533 chr17:36563609-36563867 2444
NA ENSDARG00000089365 chr17:53841299-53841681 5711
slc39a9 ENSDARG00000070447 chr17:48162123-48162427 -117514
zgc:55683 ENSDARG00000038099 chr17:43028143-43028838 -29815
zgc:55683 ENSDARG00000038099 chr17:43032161-43032758 -25797
cd82b ENSDARG00000026070 chr18:27574893-27575034 54537
LOC563500 ENSDARG00000003210 chr18:6736697-6736935 8680
LOC570903 ENSDARG00000075942 chr18:26385466-26385876 69452
LOC570903 ENSDARG00000075942 chr18:26390178-26390375 64740
NA ENSDARG00000093518 chr18:21796441-21796609 -62414
NA ENSDARG00000082214 chr18:17360608-17360789 -6301
zgc:112052 ENSDARG00000058857 chr18:12608555-12608783 2254
fam46bb ENSDARG00000011797 chr19:13956127-13957291 -49905
fam49a ENSDARG00000035907 chr19:31902703-31902949 23852
NA ENSDARG00000093827 chr19:17964741-17964949 -20539
NA ENSDARG00000082818 chr19:29067328-29067524 -139703
tert ENSDARG00000042637 chr19:619038-619394 12435
zgc:92022 ENSDARG00000077204 chr19:47091263-47091390 -43480
fggy ENSDARG00000038667 chr2:135220-135698 -19275
itgb1b ENSDARG00000053255 chr2:46188008-46188395 -85555
itgb1b ENSDARG00000053255 chr2:46188774-46189008 -86321
LOC100333415 ENSDARG00000094038 chr2:47184247-47184407 -1453
LOC555599 ENSDARG00000074233 chr2:14137740-14138067 -79958
LOC555599 ENSDARG00000074233 chr2:14149258-14149460 -91476
NA ENSDARG00000092506 chr2:19015273-19016038 29826
NA ENSDARG00000092506 chr2:19022643-19023076 37196
sept2 ENSDARG00000027590 chr2:22046968-22047162 -2382
sept2 ENSDARG00000027590 chr2:22047300-22047601 -2050
zgc:66475 ENSDARG00000054999 chr2:13838804-13839334 98322
exoc1 ENSDARG00000043019 chr20:25860272-25860469 47942
papola ENSDARG00000009585 chr20:4645227-4645663 134626
ptk2bb ENSDARG00000039577 chr20:19993147-19993631 -56856
trappc8 ENSDARG00000038866 chr20:6555883-6556112 25691
trappc8 ENSDARG00000038866 chr20:6556736-6556950 24838
bcr ENSDARG00000079286 chr21:15592920-15593123 -29263
fgf1b ENSDARG00000042811 chr21:42708010-42708492 45086
LOC100007635 ENSDARG00000069766 chr21:25263159-25263294 -66173
NA ENSDARG00000089914 chr21:32466759-32467055 -3998
NA ENSDARG00000091137 chr21:41207824-41208160 391
wbscr27 ENSDARG00000069507 chr21:25220961-25221262 -38947
wbscr27 ENSDARG00000069507 chr21:25237452-25237962 -55438
insrb ENSDARG00000071524 chr22:11162561-11162866 1833
LOC100535720 ENSDARG00000089663 chr22:34573217-34573409 -101190




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
NA ENSDARG00000091259 chr22:28887915-28888125 15118
NA ENSDARG00000091259 chr22:28947428-28947637 74631
NA ENSDARG00000091867 chr22:4795617-4795814 -9384
NA ENSDARG00000095069 chr22:13224042-13224184 27573
wu:fu71h07 ENSDARG00000075617 chr22:28499496-28499790 58376
wu:fu71h07 ENSDARG00000075617 chr22:28513009-28513223 71889
wu:fu71h07 ENSDARG00000075617 chr22:28523402-28523792 82282
LOC100536777 ENSDARG00000087644 chr23:7822418-7823267 17485
NA ENSDARG00000091528 chr23:2693370-2693499 4263
NA ENSDARG00000093398 chr23:16203872-16204266 -48510
scube3 ENSDARG00000011490 chr23:41766084-41766226 -63926
si:zfos-452g4.1 ENSDARG00000071271 chr23:12721890-12722013 70472
si:zfos-452g4.1 ENSDARG00000071271 chr23:12729052-12729254 77634
si:zfos-452g4.1 ENSDARG00000071271 chr23:12734468-12734722 83050
si:zfos-452g4.1 ENSDARG00000071271 chr23:12741107-12741232 89689
si:zfos-452g4.1 ENSDARG00000071271 chr23:12744645-12745332 93227
si:zfos-452g4.1 ENSDARG00000071271 chr23:12758303-12758499 106885
si:zfos-452g4.1 ENSDARG00000071271 chr23:12763473-12764025 112055
si:zfos-452g4.1 ENSDARG00000071271 chr23:12774581-12774872 123163
fen1 ENSDARG00000011404 chr24:11697705-11698486 16643
fen1 ENSDARG00000011404 chr24:11702818-11703052 21756
fen1 ENSDARG00000011404 chr24:11726365-11726685 45303
fen1 ENSDARG00000011404 chr24:11726876-11727170 45814
fen1 ENSDARG00000011404 chr24:11735724-11736842 54662
fen1 ENSDARG00000011404 chr24:11737897-11738166 56835
NA ENSDARG00000053943 chr24:12340714-12341620 -114071
NA ENSDARG00000053943 chr24:12342132-12342824 -115489
NA ENSDARG00000053943 chr24:12351358-12351665 -124715
NA ENSDARG00000053943 chr24:12354417-12354629 -127774
NA ENSDARG00000053943 chr24:12361317-12361514 -134674
NA ENSDARG00000053943 chr24:12372048-12372278 -145405
NA ENSDARG00000053943 chr24:12376201-12376328 -149558
NA ENSDARG00000053943 chr24:12387189-12387322 -160546
NA ENSDARG00000053943 chr24:12395790-12395989 -169147
nog2 ENSDARG00000043066 chr24:40367831-40368046 -38010
pdcd6 ENSDARG00000005220 chr24:12410825-12411026 180715
pdcd6 ENSDARG00000005220 chr24:12426158-12426376 165382
pdcd6 ENSDARG00000005220 chr24:12429708-12430130 161832
pdcd6 ENSDARG00000005220 chr24:12431275-12431490 160265
pdcd6 ENSDARG00000005220 chr24:12443289-12443483 148251
pdcd6 ENSDARG00000005220 chr24:12457135-12457362 134405
pdcd6 ENSDARG00000005220 chr24:12457785-12458035 133755
zgc:91999 ENSDARG00000046122 chr24:39764439-39764914 -3941
LOC100331323 ENSDARG00000051763 chr25:35971729-35972032 -7740
LOC571902 ENSDARG00000088171 chr25:27506231-27506538 31189




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
LOC571902 ENSDARG00000088171 chr25:27522017-27522236 15403
LOC571902 ENSDARG00000088171 chr25:27522575-27522890 14845
NA ENSDARG00000096101 chr25:27101554-27101863 -3959
NA ENSDARG00000096101 chr25:27102008-27102204 -4413
NA ENSDARG00000096101 chr25:27111104-27111557 -13509
NA ENSDARG00000096101 chr25:27120013-27120203 -22418
NA ENSDARG00000096101 chr25:27131607-27131760 -34012
NA ENSDARG00000096101 chr25:27132761-27132890 -35166
NA ENSDARG00000096101 chr25:27138273-27138467 -40678
NA ENSDARG00000096101 chr25:27161274-27161583 -63679
NA ENSDARG00000096101 chr25:27161858-27162272 -64263
NA ENSDARG00000096101 chr25:27162919-27163274 -65324
NA ENSDARG00000096101 chr25:27171454-27171690 -73859
NA ENSDARG00000096101 chr25:27172826-27173163 -75231
NA ENSDARG00000096101 chr25:27181165-27181558 -83570
NA ENSDARG00000096101 chr25:27186737-27186946 -89142
NA ENSDARG00000096101 chr25:27193482-27193689 -95887
elavl3 ENSDARG00000014420 chr3:46942840-46943019 -86871
LOC553459 ENSDARG00000035706 chr3:56206695-56207410 -26561
LOC553459 ENSDARG00000035706 chr3:56207487-56207712 -27353
NA ENSDARG00000068178 chr3:1652514-1652648 -39987
NA ENSDARG00000075830 chr3:30778932-30779074 -2594
pmp22a ENSDARG00000032724 chr3:48092797-48093166 34602
pmp22a ENSDARG00000032724 chr3:48096785-48097192 38590
pmp22a ENSDARG00000032724 chr3:48102670-48102904 44475
il22 ENSDARG00000045673 chr4:12610970-12611096 2360
LOC100147933 ENSDARG00000091005 chr4:51601690-51601817 11872
NA ENSDARG00000086238 chr4:26154107-26154539 36523
NA ENSDARG00000086238 chr4:26169956-26171201 52372
NA ENSDARG00000086238 chr4:26176755-26176948 59171
NA ENSDARG00000086238 chr4:26177968-26178235 60384
NA ENSDARG00000086238 chr4:26191518-26191803 73934
NA ENSDARG00000086278 chr4:27876970-27877868 82913
NA ENSDARG00000086278 chr4:27902163-27903077 57720
NA ENSDARG00000086278 chr4:27911183-27911383 48700
NA ENSDARG00000078499 chr4:30408384-30408520 -29472
NA ENSDARG00000094305 chr4:40099863-40100010 -61119
NA ENSDARG00000087202 chr4:41898760-41898913 -9897
NA ENSDARG00000087540 chr4:45582196-45582355 -5952
NA ENSDARG00000087540 chr4:45593724-45594057 -17480
NA ENSDARG00000094250 chr4:47635392-47635526 -7877
NA ENSDARG00000085067 chr4:61295222-61295456 350
NA ENSDARG00000085168 chr4:61297523-61298345 -589
slc6a1 ENSDARG00000041205 chr4:26217076-26217276 -57486
usp6nl ENSDARG00000022187 chr4:22809099-22809246 515




Gene Name Ensembl ID Location of peak
Distance to 
Start Site
zgc:174703 ENSDARG00000091214 chr4:32657981-32658107 -16085
NA ENSDARG00000060592 chr5:3346471-3346667 -144431
NA ENSDARG00000060592 chr5:3355635-3355779 -135267
NA ENSDARG00000080296 chr5:48660248-48660538 -15990
NA ENSDARG00000017209 chr5:64236662-64237201 32966
NA ENSDARG00000084124 chr5:52135598-52135883 126519
NA ENSDARG00000086890 chr5:62203100-62203304 95042
zgc:158463;LOC
100151188 ENSDARG00000089382 chr5:1193662-1193855 -1071
zgc:171734 ENSDARG00000004864 chr5:60097333-60097902 -50411
zgc:171734 ENSDARG00000004864 chr5:60106585-60106987 -41159
zgc:171734 ENSDARG00000004864 chr5:60113970-60114341 -33774
foxd3 ENSDARG00000021032 chr6:31791268-31791735 -5268
LOC100334891 ENSDARG00000096307 chr6:402631-402772 29955
NA ENSDARG00000084916 chr6:25967670-25967970 -50554
pou4f1 ENSDARG00000005559 chr6:4471831-4471962 39490
pttg1ipa ENSDARG00000090156 chr6:11014221-11014287 -11825
dnaja2 ENSDARG00000023921 chr7:44647925-44648143 -1690
dnaja2 ENSDARG00000023921 chr7:44648297-44648443 -2062
LOC100334018 ENSDARG00000033909 chr7:73962114-73962455 -2428
LOC557301 ENSDARG00000035852 chr7:54472297-54472976 -49969
LOC557301 ENSDARG00000035852 chr7:54478003-54478748 -55675
LOC559690 ENSDARG00000056389 chr7:64238243-64238779 -58620
LOC559690 ENSDARG00000056389 chr7:64238914-64240240 -57949
LOC559690 ENSDARG00000056389 chr7:64249256-64250023 -47607
LOC559690 ENSDARG00000056389 chr7:64250225-64251290 -46638
LOC796719 ENSDARG00000086394 chr7:56297697-56298092 -17239
NA ENSDARG00000087722 chr7:66271280-66271519 -49940
NA ENSDARG00000087722 chr7:66271753-66271969 -49467
NA ENSDARG00000087722 chr7:66280759-66281050 -40461
NA ENSDARG00000019800 chr7:7775340-7775470 -5063
NA ENSDARG00000088585 chr7:66165689-66165886 -17407
NA ENSDARG00000088585 chr7:66198484-66198683 -50202
NA ENSDARG00000088585 chr7:66212162-66212399 -63880
NA ENSDARG00000088585 chr7:66222821-66223305 -74539
NA ENSDARG00000088585 chr7:66223350-66223855 -75068
NA ENSDARG00000088585 chr7:66234149-66234356 -85867
penkb ENSDARG00000036045 chr7:59893527-59893777 -38284
si:dkey-119o24.1 ENSDARG00000061922 chr7:70993620-70994084 -25880
si:dkey-119o24.1 ENSDARG00000061922 chr7:70996891-70997108 -22609
si:dkey-119o24.1 ENSDARG00000061922 chr7:71006863-71007069 -12637
zgc:158420 ENSDARG00000079660 chr7:66048349-66048583 -6423
zgc:158420 ENSDARG00000079660 chr7:66049001-66049495 -5771
zgc:165452 ENSDARG00000090255 chr7:70982240-70982468 -22527
zgc:165452 ENSDARG00000090255 chr7:70982611-70983221 -22898








Gene Name Ensembl ID Location of peak
Distance to 
Start Site
NA ENSDARG00000084999 chr8:519363-519729 353
NA ENSDARG00000075277 chr8:36422191-36422616 -125824
NA ENSDARG00000077244 chr8:35925108-35925329 -26965
NA ENSDARG00000092712 chr8:40103095-40103218 27813
NA ENSDARG00000088400 chr8:40247888-40248103 53984
NA ENSDARG00000088400 chr8:40248285-40248488 53587
NA ENSDARG00000088942 chr8:41350325-41350564 33624
NA ENSDARG00000088942 chr8:41355644-41355847 28305
NA ENSDARG00000088942 chr8:41357646-41357852 26303
NA ENSDARG00000088942 chr8:41361692-41362035 22257
si:busm1-
160c18.3 ENSDARG00000093706 chr8:35935299-35936181 -21037
si:busm1-
160c18.3 ENSDARG00000093706 chr8:35937494-35937960 -18842
si:busm1-
160c18.3 ENSDARG00000093706 chr8:35947560-35948243 -8776
si:busm1-
228j01.6;zgc:12
3114 ENSDARG00000041705 chr8:45716003-45716507 -42563
srxn1 ENSDARG00000079160 chr8:29401177-29401418 5585
ubiad1 ENSDARG00000013009 chr8:55629937-55630202 13535
cbsb ENSDARG00000010946 chr9:9395184-9395613 55180
LOC100332907 ENSDARG00000053572 chr9:53272803-53272928 32388
LOC100333076 ENSDARG00000090974 chr9:16113292-16113482 91721
NA ENSDARG00000086154 chr9:5770533-5770779 -1678
NA ENSDARG00000095815 chr9:9348643-9348770 55563
NA ENSDARG00000095815 chr9:9351363-9351552 58283
NA ENSDARG00000088064 chr9:52386867-52387076 -9782
NA ENSDARG00000093038 chr9:16015324-16015576 -50033
NA ENSDARG00000093038 chr9:16023313-16023477 -58022
zgc:171429 ENSDARG00000077119 chr9:8864668-8864810 -86292




ADDITIONAL PRDM1A TARGETS OF INTEREST IDENTIFIED BY RNA-SEQ 
 
 
Gene Name Ensembl ID WT FPKM
prdm1a  MO 
FPKM
Fold change in 
prdm1a MO
alcama ENSDARG00000026531 28.499 25.474 -1.12
alcamb ENSDARG00000058538 569.069 201.173 -2.83
azin1a ENSDARG00000052789 7.63762 22.4954 2.95
bmp6 ENSDARG00000015686 1.62866 3.41459 2.10
c3a ENSDARG00000012694 4.13781 2.00024 -2.07
casp8 ENSDARG00000058325 1.873 80.7433 43.11
cdh11 ENSDARG00000021442 18.5836 35.1647 1.89
cdh6 ENSDARG00000014522 55.0885 107.744 1.96
cdon ENSDARG00000061328 11.9509 10.6331 -1.12
crabp2b ENSDARG00000030449 93.2025 167.411 1.80
cxcl12b ENSDARG00000055100 50.4283 70.5062 1.40
dclk2 ENSDARG00000034093 2.57301 3.46805 1.35
dgcr14 ENSDARG00000060922 14.2939 19.5131 1.37
dla ENSDARG00000010791 27.7296 19.3845 -1.43
dlb ENSDARG00000004232 7.10104 3.34494 -2.12
dld ENSDARG00000020219 64.5365 32.3986 -1.99
dlx3b ENSDARG00000014626 75.591 46.8279 -1.61
dlx4b ENSDARG00000071560 4.22885 0.78548 -5.38
dlx5a ENSDARG00000042296 4.41266 2.24431 -1.97
dnttip2 ENSDARG00000057648 64.1385 133.924 2.09
ednra ENSDARG00000011876 9.1273 27.2469 2.99
eya1 ENSDARG00000014259 9.25072 4.5214 -2.05
eya2 ENSDARG00000018984 4.67495 4.13347 -1.13
six1b ENSDARG00000026473 3.93087 2.53044 -1.55
f11r ENSDARG00000017320 77.2714 120.753 1.56
fam84a ENSDARG00000018921 4.10116 9.24465 2.25
fbn2b ENSDARG00000016744 16.2348 22.9189 1.41
fgf2 ENSDARG00000075031 7.4745 44.9495 6.01
foxh1 ENSDARG00000055630 12.3949 22.3414 1.80
ftr82 ENSDARG00000055647 23.1945 35.8611 1.55
fzd10 ENSDARG00000068213 29.7408 26.4562 -1.12
gata3 ENSDARG00000016526 86.006 56.0035 -1.54
gbx1 ENSDARG00000071418 8.35482 11.2177 1.34




Gene Name Ensembl ID WT FPKM
prdm1a  MO 
FPKM
Fold change in 
prdm1a MO
her12 ENSDARG00000032963 29.4101 20.3986 -1.44
her15.1 ENSDARG00000054562 38.2283 13.487 -2.83
her2 ENSDARG00000038205 21.0741 5.99727 -3.51
her3 ENSDARG00000076857 51.4833 44.1642 -1.17
her4.1 ENSDARG00000056732 3.13843 1.82881 -1.72
her4.2 ENSDARG00000094426 4.95693 1.49225 -3.32
her4.5 ENSDARG00000056729 5.32606 1.64897 -3.23
her9 ENSDARG00000056438 72.3126 88.3042 1.22
hesx1 ENSDARG00000054509 56.1713 138.347 2.46
hoxa3a ENSDARG00000036231 6.5492 8.85625 1.35
hoxa5a ENSDARG00000001784 1.60853 4.85773 3.02
id1 ENSDARG00000040764 676.278 587.084 -1.15
id3 ENSDARG00000054823 114.681 98.937 -1.16
itgb1bp1 ENSDARG00000007169 6.5328 3.35636 -1.95
kctd15a ENSDARG00000045893 42.9811 20.3368 -2.11
klf2b ENSDARG00000040432 10.4738 15.8536 1.51
lats2 ENSDARG00000078864 13.6702 18.9377 1.39
lfng ENSDARG00000037879 70.2409 173.899 2.48
lin28a ENSDARG00000016999 107.902 237.964 2.21
lmo4a ENSDARG00000013853 44.0462 82.0666 1.86
meis3 ENSDARG00000002795 51.7046 31.2625 -1.65
mki67ip ENSDARG00000040666 141.599 233.621 1.65
MMP15 ENSDARG00000013072 9.80603 8.25816 -1.19
mmp2 ENSDARG00000017676 1.66418 16.743 10.06
msxb ENSDARG00000008886 58.1962 52.6494 -1.11
msxc ENSDARG00000015674 11.1357 5.41115 -2.06
msxe ENSDARG00000007641 24.967 19.9623 -1.25
ncam1a ENSDARG00000056181 2.48378 1.67725 -1.48
neurod4 ENSDARG00000003469 4.00424 1.93786 -2.07
neurog1 ENSDARG00000056130 16.3144 13.7929 -1.18
nkx2.2b ENSDARG00000052550 2.98936 5.00988 1.68
nrg1 ENSDARG00000068458 2.49427 4.38155 1.76
OVOL1 ENSDARG00000078256 7.5208 13.6208 1.81
PARD3B ENSDARG00000067785 3.27133 5.14495 1.57
pax6a ENSDARG00000045045 11.9268 4.18813 -2.85
pax7b ENSDARG00000070818 0.717283 2.62404 3.66
pdcd4a ENSDARG00000021702 50.5727 26.5576 -1.90
pitx3 ENSDARG00000070069 8.7694 7.0049 -1.25
prdm8 ENSDARG00000025017 9.06291 7.62559 -1.19
rab32a ENSDARG00000029036 4.65421 7.08264 1.52
RAC1 ENSDARG00000094613 1.27946 19.5293 15.26
rasl11b ENSDARG00000015611 15.9186 112.532 7.07




Gene Name Ensembl ID WT FPKM
prdm1a  MO 
FPKM
Fold change in 
prdm1a MO
rfx2 ENSDARG00000013575 25.0293 47.8414 1.91
rhov ENSDARG00000070434 21.2656 28.4323 1.34
rnd3a ENSDARG00000076799 14.4117 37.5136 2.60
ROCK2 ENSDARG00000090999 2.145 6.07542 2.83
ROCK2 ENSDARG00000093343 1.52673 7.25904 4.75
ROCK2 ENSDARG00000087746 1.38958 6.86075 4.94
rock2b ENSDARG00000004877 18.0525 16.9276 -1.07
sash1a ENSDARG00000007179 56.7234 15.2273 -3.73
sfrp1a ENSDARG00000035521 59.6884 116.108 1.95
slc38a3 ENSDARG00000014587 44.9667 63.5959 1.41
snai1a ENSDARG00000056995 76.5988 136.655 1.78
twistnb ENSDARG00000024416 17.3089 22.5254 1.30
SOX13 ENSDARG00000030297 12.1856 8.57804 -1.42
sox2 ENSDARG00000070913 43.0087 27.8805 -1.54
sox4b ENSDARG00000043235 6.99869 22.365 3.20
sox9b ENSDARG00000043923 9.38693 3.18431 -2.95
sp7 ENSDARG00000019516 12.0909 5.5001 -2.20
sqstm1 ENSDARG00000075014 10.7446 15.3531 1.43
tbx1 ENSDARG00000031891 8.53971 21.837 2.56
tfap4 ENSDARG00000074641 23.265 13.9334 -1.67
traf4a ENSDARG00000003963 4.15231 8.20804 1.98
txnipa ENSDARG00000036107 65.3748 159.394 2.44
vim ENSDARG00000010008 11.3487 7.913 -1.43
wnt10b ENSDARG00000040925 3.68418 2.38893 -1.54
wnt8b ENSDARG00000006911 4.73004 3.49301 -1.35
zfp36l1b ENSDARG00000021443 7.26277 12.1642 1.67
zic2b ENSDARG00000037178 128.236 110.414 -1.16
zic5 ENSDARG00000016022 3.0379 1.11316 -2.73
smad5 ENSDARG00000037238 57.1664 99.3302 1.74
lims1 ENSDARG00000026985 22.5407 28.2585 1.25
mafba ENSDARG00000017121 8.39872 7.07928 -1.19
mycb ENSDARG00000007241 11.73 47.5331 4.05
mych ENSDARG00000077473 115.061 94.983 -1.21
mycn ENSDARG00000006837 129.661 122.726 -1.06
